Introduction
Optic nerve cysts are rare, often asymptomatic lesions associated with the optic nerve, presenting significant diagnostic and management challenges for clinicians. These cystic structures may occur as primary anomalies or secondary manifestations of systemic or local pathological processes. Although generally benign, their potential to mimic other optic nerve pathologies, such as tumors or inflammatory conditions, necessitates a thorough understanding of their clinical, radiological, and histopathological characteristics. Due to their rarity and variability in presentation, substantial gaps in the literature persist, making them an important area for further investigation and study.[1]
The optic nerve plays a critical role in visual processing, making any pathological change in its structure or function a potential threat to vision. Optic nerve cysts encompass various conditions, including arachnoid cysts, neuroepithelial cysts, and parasitic cysts. The etiology of these cysts remains a subject of investigation, with hypotheses ranging from congenital malformations to acquired inflammatory or infectious causes. Regardless of origin, these cysts may exert pressure on the optic nerve, leading to symptoms such as visual field defects, optic disc swelling, or, in severe cases, vision loss. Understanding the underlying mechanisms of optic nerve cyst formation is essential to improve diagnostic accuracy and patient outcomes.[2]
Epidemiological data on optic nerve cysts are limited due to their rarity. These cysts are often identified incidentally during imaging for unrelated complaints or in the context of a comprehensive evaluation for visual disturbances. The prevalence of these cysts may be underestimated because many cases remain asymptomatic. Patients typically present with vague and nonspecific symptoms, such as headaches, visual blurring, or decreased visual acuity when symptomatic. Occasionally, optic nerve cysts may manifest with more dramatic presentations, such as diplopia, proptosis, or even optic neuropathy. These diverse presentations underscore the need for heightened clinical awareness and systematic evaluation.[3]
Advances in imaging modalities, such as magnetic resonance imaging (MRI) and computed tomography (CT), have revolutionized the identification and characterization of optic nerve cysts. In particular, MRI provides superior soft tissue contrast, making it the preferred imaging modality for evaluating these lesions. T1- and T2-weighted sequences can reveal the cyst's size, location, and relationship to surrounding structures, whereas gadolinium contrast may help differentiate benign cysts from malignant or vascular lesions. Despite these technological advances, the overlap in imaging features between benign cysts and other optic nerve pathologies continues to pose diagnostic challenges, particularly in the absence of biopsy-confirmed data.[4]
The management of optic nerve cysts depends largely on their size, location, and symptomatology. Asymptomatic cysts detected incidentally are often managed conservatively with regular imaging and clinical follow-up. However, symptomatic cases may require intervention, ranging from pharmacological therapies to surgical decompression. Recent developments in minimally invasive surgical techniques and endoscopic approaches have significantly improved cyst excision's safety and efficacy while preserving optic nerve function. Despite these advancements, questions remain regarding the optimal timing and indications for surgical intervention, especially in borderline cases where the risk of intervention must be carefully weighed against potential complications.[5]
From a broader perspective, the management of optic nerve cysts exemplifies the importance of interprofessional collaboration. Ophthalmologists, neurologists, radiologists, and neurosurgeons must collaborate to achieve accurate diagnosis and effective treatment planning. Emerging research on biomarkers and genetic predispositions holds promise for early detection and personalized management strategies, which may one day refine clinical decision-making. In addition, public health initiatives aimed at increasing awareness among healthcare professionals about the presentation and implications of optic nerve cysts further improve patient outcomes.[6]
This activity aims to consolidate current knowledge on optic nerve cysts, focusing on the latest advancements in diagnosis and management while addressing existing gaps in the literature and proposing potential directions for future research. Emphasis is placed on exploring the role of novel imaging modalities, minimally invasive interventions, and the development of standardized treatment guidelines. Furthermore, this review highlights the importance of integrating fundamental science discoveries with clinical practice to unravel the pathophysiological mechanisms underlying optic nerve cyst formation.
In conclusion, optic nerve cysts represent a complex and underexplored area of neuro-ophthalmology that warrants greater attention. The potential of these lesions to masquerade as other optic nerve pathologies necessitates a high index of suspicion and a systematic diagnostic approach. With the advent of advanced imaging techniques, targeted therapies, and multidisciplinary care models, there is significant potential to enhance the management of this condition. By reviewing the existing body of knowledge and exploring emerging trends, this article aims to contribute to the ongoing discourse and inspire further research into the enigmatic domain of optic nerve cysts.[7]
Etiology
Register For Free And Read The Full Article
Search engine and full access to all medical articles
10 free questions in your specialty
Free CME/CE Activities
Free daily question in your email
Save favorite articles to your dashboard
Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Etiology
Optic nerve cysts can arise from various etiologies, including idiopathic origins, associations with meningiomas, meningoceles, arachnoid cysts, neuroepithelial cysts, and post-traumatic or postoperative cysts. Specifically, the optic nerve sheath meningocele is a dilation of the optic nerve sheath and expansion of the subarachnoid or subdural cerebrospinal fluid (CSF)-filled space around the optic nerve. An arachnoid cyst is a benign proliferation of normal fibrovascular tissue of the leptomeninges around the optic nerve. Neuroepithelial cysts are rare lesions typically present in the ventricles or cerebral parenchyma. These cysts have rarely been reported in the intracranial portion of the optic nerve.[8]
Optic nerve cysts may also be iatrogenic. For example, Naqvi et al [9] reported 2 cases of cysts that developed after optic nerve sheath fenestration. These cysts are uncommon lesions associated with the optic nerve and adjacent structures. The etiology of these cysts encompasses a broad spectrum of congenital, acquired, infectious, and idiopathic causes, with mechanisms varying depending on the specific type of cyst. Although some arise as primary anomalies, others develop secondary to systemic diseases, trauma, or inflammatory processes. The following section provides a detailed review of the literature on the various etiologies of optic nerve cysts:
Congenital Etiologies
- Arachnoid cysts: These benign, CSF-filled sacs arise from developmental anomalies in the arachnoid membrane surrounding the optic nerve. Aberrant splitting or duplication of the arachnoid layer during embryogenesis results in a cystic space that may exert pressure on the optic nerve.
- Neuroepithelial cysts: These cysts, believed to originate from primitive neuroepithelial tissue, are typically congenital and are associated with aberrations in optic nerve sheath development.
- Colobomatous cysts: Colobomas of the optic nerve are congenital anomalies resulting from incomplete closure of the embryonic fissure. Due to fluid accumulation within the maldeveloped tissues, cystic dilatations may form and be associated with these colobomas.[10]
Traumatic Etiologies
- Post-traumatic cysts: Direct or indirect trauma to the optic nerve or surrounding orbital structures may cause cysts. These cysts result from localized disruptions in the arachnoid sheath or vitreous prolapse into the optic nerve head.
- Post-surgical cysts: Iatrogenic causes, such as complications from orbital decompression or optic nerve sheath fenestration, may lead to cyst formation due to scarring and fluid trapping.[11]
Inflammatory and Infectious Causes
- Parasitic cysts:
- Hydatid cysts (Echinococcus): In rare cases, parasitic infections involving Echinococcus granulosus can affect the optic nerve, causing cystic masses that exert pressure on the optic nerve and surrounding tissues.Cysticercosis: Caused by Taenia solium larvae, these cysts may localize to the optic nerve and are often accompanied by systemic neurocysticercosis.
- Post-infectious gliosis: Chronic inflammation secondary to infections such as tuberculosis or syphilis can lead to gliotic scarring and cyst formation within or near the optic nerve.[12]
Neoplastic Associations
- Cystic changes in tumors: Optic nerve gliomas or meningiomas may develop cystic degeneration, either due to necrosis of tumor tissue or secondary to disruption of normal CSF dynamics.
- Peripapillary retinal cysts: Tumors near the optic nerve, such as hemangioblastomas, can lead to fluid leakage and cyst formation in the optic disc or nearby structures.[13]
Idiopathic Cysts
Some optic nerve cysts are classified as idiopathic when, despite thorough investigation, no identifiable cause is found. Idiopathic orbital inflammation may also contribute to cystic structure formation near the optic nerve.[14]
Degenerative or Vascular Causes
- Chronic ischemia: Vascular insufficiency, particularly in the context of systemic diseases, such as diabetes mellitus or hypertension, may result in microcystic degeneration of the optic nerve.
- Cystic degeneration in aging: In some elderly patients, cysts may arise due to chronic degenerative changes in optic nerve tissue, although these are typically incidental findings without clinical significance.[15]
Iatrogenic Causes
- Post-radiation changes: Radiation therapy for tumors in the orbit or brain may induce cyst formation as a late complication due to necrosis or gliosis of optic nerve tissue.
- Corticosteroid-induced cysts: Prolonged corticosteroid use in treating inflammatory or autoimmune optic neuropathies may contribute to localized cystic changes.[16]
Systemic and Genetic Associations
- Phakomatoses: Cyst formation has been observed in conditions, such as neurofibromatosis type 1 (NF1), which can be associated with optic nerve gliomas and secondary cystic changes.
- Inherited syndromes: In rare cases, genetic conditions such as Marome or Stickler syndrome may predispose to optic nerve or ocular cyst formation due to connective tissue abnormalities.[17]
Vitreous Abnormalities
- Vitreous prolapse: Disruption of the vitreous, particularly in association with posterior vitreous detachment or high myopia, may lead to anterior cystic changes near the optic disc. These changes are typically not true optic nerve cysts but may mimic their presentation.[18]
Miscellaneous Causes
- Post-infectious granulomas: Conditions such as sarcoidosis or granulomatosis with polyangiitis may involve the optic nerve, with granuloma formation occasionally leading to cystic structures.
- Optic nerve pits: Congenital optic nerve pits are often associated with cystic changes or serous detachment of the macula, mimicking the effects of optic nerve cysts.[19]
The etiology of optic nerve cysts is complex, with contributions from congenital, inflammatory, and acquired mechanisms. Advances in imaging and histopathological techniques have improved the characterization of these lesions. However, variability in etiology emphasizes the need for a multidisciplinary diagnostic approach and a high index of suspicion, particularly in cases presenting with atypical symptoms or progressive visual decline.
In conclusion, optic nerve cysts can have diverse etiologies, ranging from congenital malformations to systemic diseases and acquired conditions. Understanding their etiology is critical for accurately diagnosing, treating, and counseling affected patients. Further research is needed to elucidate the mechanisms underlying their formation and refine treatment strategies for symptomatic cases.[20]
Epidemiology
The frequency of cysts is difficult to determine due to their varied etiologies across different age groups. The cysts may also be asymptomatic and never diagnosed. For example, Lunardi et al [21] reported that only 31 cases of optic sheath meningocele have been documented in the literature. Optic nerve cysts are rare lesions, with their epidemiology not extensively documented due to their infrequent presentation and the diverse etiological factors underlying their development. The prevalence data is limited and primarily derived from case reports, small case series, and studies of specific conditions. The following section provides a detailed analysis of the epidemiological aspects of optic nerve cysts:
Prevalence and Incidence
Optic nerve cysts are rare, and their prevalence varies depending on the underlying type of cyst and the population studied. Congenital optic nerve cysts, such as arachnoid cysts, are more frequently reported in pediatric populations. In contrast, acquired cysts are typically observed in adults, often resulting from trauma, inflammatory conditions, or neoplastic processes. The incidence of parasitic cysts, such as those caused by cysticercosis or hydatid disease, is more common in endemic regions such as South America, sub-Saharan Africa, and Southeast Asia, reflecting regional disparities in healthcare and sanitation.[5][22]
Demographics
- Age distribution:
- Congenital optic nerve cysts, including neuroepithelial or colobomatous cysts, are typically diagnosed in infancy or early childhood due to associated visual or developmental abnormalities.
- Acquired optic nerve cysts are more common in middle-aged and older adults. These cysts are often present as secondary to systemic diseases or degenerative changes.
- Parasitic optic nerve cysts are typically observed in younger individuals from endemic regions, reflecting the higher risk of exposure.[23]
- Sex distribution:
- There is no definitive evidence of a significant sex predilection for optic nerve cysts. However, certain associated conditions, such as NF1, which may involve optic nerve gliomas and secondary cyst formation, may show a slight female predominance due to genetic inheritance patterns.[24]
Geographic Distribution
- Endemic areas for parasitic cysts:
- Optic nerve cysts associated with parasitic infections, such as cysticercosis and echinococcosis, are more common in regions where these diseases are endemic, including parts of Latin America, Africa, Southeast Asia, and the Indian subcontinent.
- Hydatid cysts caused by E granulosus or E multilocularis are more frequently reported in rural areas where livestock farming and poor sanitation practices increase exposure risks.[25]
- Industrialized countries:
- In developed regions, optic nerve cysts are more likely to be associated with trauma, degenerative changes, or neoplastic conditions rather than infectious causes.[26]
Associated Conditions
- Congenital anomalies:
- Conditions such as optic nerve coloboma or optic nerve pits, which predispose to cyst formation, are rare. The reported incidence of optic nerve coloboma is approximately 0.14 per 10,000 live births.[27]
- Systemic diseases:
- NF1, which involves optic nerve gliomas and can lead to cystic degeneration, is prevalent worldwide, affecting 1 in 3000 to 4000 individuals.
- Sarcoidosis and granulomatosis with polyangiitis, which may involve the optic nerve and result in cystic changes, are more common in adults and vary in incidence across geographic and racial groups.[28]
- Parasitic infections:
- Neurocysticercosis, caused by T solium, is one of the most common parasitic infections affecting the central nervous system, including the optic nerve, with a prevalence of up to 10% in endemic regions.
- Ocular hydatid cysts are rare but more frequently observed in countries where echinococcal disease is prevalent.[29]
Risk Factors
Several risk factors have been identified for optic nerve cyst formation, including:
- Congenital:
- Genetic syndromes, such as NF1 or Marfan syndrome, and structural anomalies, such as colobomas or optic pits.[30]
- Trauma:
- Blunt or penetrating orbital trauma and iatrogenic causes, such as post-surgical scarring.[31]
- Infectious:
- Living in regions endemic for parasitic diseases such as cysticercosis or hydatid disease.[32]
- Neoplastic:
- Tumors affecting the optic nerve, such as gliomas or meningiomas, predispose to secondary cyst formation.[33]
Trends in Diagnosis
Advances in imaging modalities, such as high-resolution MRI and CT, have significantly improved the detection and characterization of optic nerve cysts. The increased accessibility of imaging in both developed and developing countries has led to more frequent identification of these lesions, even in asymptomatic individuals undergoing scans for unrelated conditions.[4]
Clinical Significance
Although optic nerve cysts are rare, their clinical significance lies in their potential to cause visual impairment and their association with systemic or infectious diseases. Early identification and management are crucial, particularly in cases where progressive enlargement or compression of the optic nerve may lead to vision loss or other neurological complications.
Although optic nerve cysts are relatively uncommon, their epidemiology reflects a broad spectrum of congenital, acquired, infectious, and idiopathic causes. Geographic, demographic, and systemic factors influence variations in prevalence. A thorough understanding of the epidemiological aspects of optic nerve cysts aids in early recognition, targeted investigations, and appropriate management, ultimately improving patient outcomes. Future research is needed to better define the incidence of these rare lesions, the risk factors, and the long-term prognosis.[34]
Pathophysiology
The pathophysiology of primary arachnoid cysts is unclear. In the setting of traumatic arachnoid cysts or post-optic nerve sheath fenestration iatrogenic cysts, Akor et al [2] proposed that trauma results in the entrapment of secretory neuroepithelial cells in the optic nerve sheath and cyst formation. In the setting of congenital cysts, these cells may be entrapped during embryogenesis. Lunardi et al [21] suggest that congenital arachnoid cysts develop through a diverticulum or blind pocket within the arachnoid membrane.
The abnormal bony structure of the orbital apex may cause optic nerve sheath meningoceles. The subarachnoid space is narrowest near the optic canal. Congenital narrowing here could cause meningoceles.[21]
In some cases of optic nerve cysts, dilation of the optic nerve sheath complex could be secondary to proximal neoplasm, vascular hamartoma, or cranio-orbital fracture. In these cases, the neoplastic tissue or fracture acts like a ball valve, allowing CSF to enter one direction into the sheath.[21]
Neuroepithelial cysts may be caused by developmental abnormalities when there is incomplete closure along the optic fissure. A more severe version of this condition is a colobomatous cyst, also known as microphthalmia with a cyst.[8] The superior end of the embryonic fissure does not close at the time of the 10 to 13 mm embryo. The edges of the fissure evert as they oppose one another, forming a cystic structure. The walls of these cysts have collagenous fibers and poorly differentiated neuroepithelium and neuroglial tissue. Cysts are connected to the sclera and may be filled with eosinophilic material or photoreceptor segments.[35]
Vision loss is believed to be due to compression of the optic nerve itself.
Optic nerve cysts, also called perineural or intraorbital cystic lesions of the optic nerve, are uncommon structural anomalies of the optic nerve. These cysts may arise from various etiologies, including congenital malformations, trauma, inflammation, neoplastic processes, or degenerative changes. Depending on their etiology and specific subtype, the pathophysiology of optic nerve cysts can be attributed to several mechanisms.[36]
Congenital Mechanisms
Congenital optic nerve cysts often result from developmental anomalies during embryogenesis. The optic nerve forms as an outgrowth of the diencephalon, and any disruption during its formation can lead to cystic changes, which include:
- Colobomatous cysts: These cysts are often associated with incomplete closure of the embryonic optic fissure, resulting in an outpouching of neural or glial tissue that forms a cystic lesion.
- Congenital anomalies of the meninges: Malformations in the dura mater, arachnoid, or pia mater surrounding the optic nerve can lead to the formation of cystic structures due to abnormal CSF dynamics or tissue protrusion.[37]
Trauma-Induced Pathophysiology
Trauma to the optic nerve or surrounding structures can lead to cyst formation through mechanisms as follows:
- Axonal injury and glial scarring: Disruption of the optic nerve fibers can lead to focal cystic degeneration or gliosis, forming cyst-like structures.
- Leakage of CSF: Damage to the meningeal sheath can allow CSF to accumulate in abnormal locations, leading to the formation of perineural cysts.[38]
Neoplastic and Inflammatory Processes
Optic nerve cysts may be secondary to the following:
- Benign tumors: Cavernous hemangiomas, meningiomas, or schwannomas may develop cystic components due to necrosis or fluid accumulation within the tumor mass.
- Infectious or inflammatory diseases: Granulomatous inflammation, such as that observed in tuberculosis or sarcoidosis, can result in liquefaction necrosis and cyst formation around or within the optic nerve.
- Parasitic infections: Echinococcosis or cysticercosis can cause cystic lesions when parasitic larvae invade the orbital tissue or optic nerve.[39]
Degenerative Changes
Chronic degenerative changes in the optic nerve can also result in cystic formations. For example:
- Axonal degeneration: Chronic optic neuropathy, such as in glaucoma or ischemic optic neuropathy, can lead to microcystic macular changes that extend to the optic nerve.
- Perineural cysts may form when the perineural spaces dilate due to chronic increased intraocular pressure or altered CSF flow.[40]
Classification and Pathophysiology of Cysts
- Subarachnoid cysts: These cysts result from abnormal CSF accumulation between the arachnoid and pia mater. They can occur due to trauma, meningitis, or congenital abnormalities in CSF flow pathways.
- Intraoptic cysts: These cysts are located within the optic nerve tissue and are associated with gliosis, degeneration, or vascular compromise.
- Perineural cysts: These cysts form around the optic nerve, often due to meningeal defects or disruption of CSF flow.[41]
Impact on Optic Nerve Function
Optic nerve cysts may affect vision due to several mechanisms.
- Compression: Cysts can compress the optic nerve axons or surrounding vasculature, leading to ischemia, demyelination, or axonal loss.
- Distortion: Structural distortion of the optic nerve sheath and surrounding tissues can impair signal transmission.
- Vascular effects: Cysts may impede blood flow to the optic nerve head or surrounding orbital structures, leading to ischemic damage.
- CSF dynamics: Disruption of normal CSF flow around the optic nerve may raise intracranial pressure, causing papilledema or other complications.[42]
Molecular and Cellular Mechanisms
- Inflammatory cascades: Chronic inflammation, as observed in autoimmune or infectious etiologies, can promote cyst formation through necrosis and fibrotic scarring.
- Matrix remodeling: Alterations in extracellular matrix components due to trauma or degeneration may develop cystic spaces within the optic nerve tissue.
- Neuroglial proliferation: Reactive gliosis, which occurs in response to nerve injury or degeneration, can create cystic spaces by disrupting the normal architecture of the optic nerve.[43]
The pathophysiology of optic nerve cysts is multifaceted, depending on their etiology, location, and underlying mechanisms. Whether congenital, traumatic, neoplastic, or degenerative, these cystic lesions disrupt the delicate balance of structural and functional components of the optic nerve, leading to potential vision impairment or loss. Understanding these mechanisms is critical for accurate diagnosis, effective management, and the development of targeted therapeutic strategies. Further research into the molecular basis of cyst formation and its impact on optic nerve function can pave the way for more refined and individualized approaches to treatment.
Histopathology
The histopathological examination of optic nerve sheath meningoceles and arachnoid cysts reveals normal meninges.[44] A colobomatous optic nerve cyst is composed of 2 layers—the inner layer, which has retinal architecture and is derived from primitive neuroretinal tissue, and the outer layer, which has vascularized connective tissue continuous with the sclera.[44] Mehta et al [8] reported a case of a neonate with a neuroepithelial cyst that was resected. Histopathological findings showed that the cyst was lined by simple cuboidal epithelium without cilia or goblet cells. No neural tissue was present; however, immunohistochemical staining was positive for S100, a marker of neural tissue.[8]
Optic nerve cysts represent a spectrum of lesions characterized by cystic changes either within or surrounding the optic nerve. Histopathologically, these lesions vary based on their underlying etiology, anatomical location, and pathological changes within the optic nerve and surrounding structures. A comprehensive histopathological analysis reveals the cellular, vascular, and structural components of cystic lesions, providing insight into their formation, progression, and clinical implications.[45]
General Features
Optic nerve cysts can be histologically classified based on their location and origin:
- Intraoptic cysts: These cysts, found within the optic nerve substance, are often lined by glial tissue or fibrous stroma. They may show evidence of axonal degeneration, demyelination, and gliosis.
- Perineural cysts: These cysts around the optic nerve typically arise from the meninges. The histology examination reveals cystic spaces lined by arachnoid or dura mater cells and may show fibrovascular or collagenous walls.
- Subarachnoid cysts: These cysts, which are associated with CSF accumulation, are enclosed by arachnoid and pia mater layers and exhibit thinning or disruption of meningeal structures.[46]
Microscopic Examination
- Cyst wall structure:
- Congenital cysts: Lined by neural or glial tissue. For example, colobomatous cysts often demonstrate remnants of retinal pigment epithelium and choroidal tissue.
- Inflammatory cysts: Exhibit infiltrates of lymphocytes, plasma cells, and macrophages. Chronic inflammation may lead to fibrotic thickening of the cyst wall.
- Traumatic or degenerative cysts: Characterized by fibrosis and gliosis, with evidence of disrupted axonal integrity.[47]
- Cyst contents:
- Fluid-filled cysts: Contain clear or proteinaceous fluid, often resembling CSF.
- Necrotic cysts: Filled with cellular debris, inflammatory exudate, or necrotic material in cases of infection or trauma.
- Hemorrhagic cysts: Show blood products and hemosiderin-laden macrophages, indicating prior bleeding episodes.[48]
- Axonal changes:
- Axonal degeneration and loss of myelin sheaths are prominent in intraoptic cysts. Reactive gliosis and astrocyte hypertrophy may accompany these changes.[49]
Specific Histopathological Findings
- Colobomatous cysts: Show disorganized neural tissue, remnants of the retina and retinal pigment epithelium, and cystic spaces filled with fluid or lipid-laden macrophages.
- Trauma-associated cysts: Exhibit fibrous scar tissue, gliosis, and macrophage infiltration. Hemorrhagic changes and disrupted axonal architecture are also common.
- Neoplastic cysts: These cysts are associated with primary or secondary optic nerve tumors, such as gliomas or meningiomas. They may show necrosis, vascular proliferation, and tumor cells.[50]
Immunohistochemical Analysis
Immunohistochemistry is often used to characterize optic nerve cysts.
- Glial fibrillary acidic protein: Highlights reactive gliosis in the cystic walls of intraoptic origin.
- CD68: Identifies macrophages in inflammatory or necrotic cysts.
- Vascular endothelial growth factor: Indicates neovascularization in cysts associated with tumors.
- Collagen stains: Demonstrate fibrotic changes in the cyst walls, especially in traumatic or degenerative lesions.[51]
Vascular and Meningeal Changes
- Vascular proliferation: Observed in neoplastic or inflammatory cysts, contributing to cyst enlargement and associated complications.
- Meningeal thickening: Found in perineural cysts, often with fibrosis or calcification of the arachnoid or dura mater layers.[52]
Differential Histopathological Features
Histopathology is crucial in differentiating optic nerve cysts from other orbital lesions, such as dermoid cysts, arachnoid cysts, and parasitic cysts.
- Dermoid cysts: Contain epithelial structures, sebaceous glands, and keratin.
- Parasitic cysts: Show parasitic larvae or eggs surrounded by granulomatous inflammation.[53]
- Glial fibrillary acidic protein: Highlights reactive gliosis in the cystic walls of intraoptic origin.
- CD68: Identifies macrophages in inflammatory or necrotic cysts.
- Vascular endothelial growth factor: Indicates neovascularization in cysts associated with tumors.
- Collagen stains: Demonstrate fibrotic changes in the cyst walls, especially in traumatic or degenerative lesions.[51]
Vascular and Meningeal Changes
- Vascular proliferation: Observed in neoplastic or inflammatory cysts, contributing to cyst enlargement and associated complications.
- Meningeal thickening: Found in perineural cysts, often with fibrosis or calcification of the arachnoid or dura mater layers.[52]
Differential Histopathological Features
Histopathology is crucial in differentiating optic nerve cysts from other orbital lesions, such as dermoid cysts, arachnoid cysts, and parasitic cysts.
- Dermoid cysts: Contain epithelial structures, sebaceous glands, and keratin.
- Parasitic cysts: Show parasitic larvae or eggs surrounded by granulomatous inflammation.[53]
Histological Implications
The histopathology of optic nerve cysts is crucial for the following:
- Understanding the underlying etiology and pathophysiological mechanisms.
- Differentiating benign from malignant lesions.
- Guiding surgical or medical management based on cyst structure and content.
Histopathological examination is crucial for diagnosing and characterizing optic nerve cysts. By providing a detailed view of the cellular and structural changes, histopathology aids in determining the etiology, assessing potential complications, and planning appropriate treatment strategies. Further studies using advanced histological and molecular techniques are needed to enhance our understanding of these rare lesions.[54]
History and Physical
Patients with optic nerve cysts may be asymptomatic or present with nonspecific orbital or neurological findings. In the setting of arachnoid cysts, visual acuity can range from 20/20 to no light perception.
Garrity et al [55] reported a case series involving 13 patients with optic nerve sheath meningocele. These patients presented with various symptoms, including headaches, decreased vision, proptosis, afferent pupillary defect, enlarged blind spot, optic disc edema, shunt vessels at the optic disc, and tortuous retinal veins.
Colobomatous cyst often involves the optic nerve itself. As the lesion grows, typically inferiorly, it may produce a palpable mass behind the lower eyelid. In some cases, lowering the lower eyelid can reveal a dark uveal pigmentation to the mass. Bilateral cases may be associated with systemic diseases, such as chiasmal glioma, polycystic kidney disease, trisomy, or Edward syndrome.[8]
Accurate diagnosis and effective management of optic nerve cysts require a detailed patient history and a thorough physical examination. Depending on their size, location, and impact on surrounding structures, these lesions can present with a spectrum of clinical features.
History
- Onset and progression of symptoms:
- Patients may report a gradual onset of symptoms, although acute presentations can occur with complications such as rupture or hemorrhage.
- Key symptoms include:
- Visual disturbances, such as blurring, reduced acuity, or field defects.
- Pain, especially if the cyst compresses adjacent nerves or tissues.
- Double vision or proptosis in advanced cases.[56]
- Associated symptoms:
- Diplopia may result from extraocular muscle involvement.
- Headaches are often due to increased intracranial pressure or cyst compression.
- Symptoms of optic neuropathy, such as decreased color vision or afferent pupillary defects, indicate optic nerve involvement.[57]
- Duration and impact:
- The chronic nature of symptoms may indicate longstanding compression or slow-growing cysts.
- Acute deterioration suggests rapid expansion, hemorrhage, or secondary inflammation.[58]
- Precipitating or associated factors:
- A history of trauma may indicate traumatic cyst formation.
- Associated systemic diseases, such as neurofibromatosis, may suggest a genetic predisposition.
- Inflammatory conditions, such as sarcoidosis or autoimmune disorders, could indicate inflammatory optic nerve cysts.[59]
- Previous interventions or diagnostics:
- Prior imaging or surgical procedures involving the orbit or optic nerve.
- A history of ocular surgeries or infections.[60]
Physical Examination
- Visual acuity testing:
- Decreased visual acuity is often an early sign of optic nerve involvement.
- Quantify the degree of impairment and assess for any disparity between the eyes.[61]
- Pupillary reflex assessment:
- Relative afferent pupillary defect is a hallmark of optic nerve dysfunction.
- An absent pupillary response may indicate severe nerve compression or ischemia.[62]
- Ophthalmoscopic examination:
- Examine the optic disc for:
- Papilledema: Indicates raised intracranial pressure.
- Optic disc pallor: Suggests chronic nerve damage.
- Cupping or atrophy: Secondary to longstanding compression.
- Examine the optic disc for:
- Look for any vascular anomalies or hemorrhages.[63]
- Visual field testing:
- Automated perimetry or confrontation testing may reveal field defects consistent with optic nerve compression.
- Common patterns include central scotomas or arcuate defects.[64]
- Proptosis evaluation:
- Exophthalmometry can quantify the degree of proptosis if present.
- Proptosis is more common in large cysts or those with significant orbital involvement.[65]
- Extraocular movements:
- Restriction in eye movements may indicate compression or involvement of extraocular muscles.
- Diplopia may occur if ocular motility is impaired.[66]
- Palpation and inspection of the orbit:
- External inspection may reveal visible swelling, asymmetry, or a palpable mass.
- Tenderness to palpation could suggest secondary inflammation or infection.[67]
- Systemic examination:
- Look for the signs of systemic diseases that may be associated with optic nerve cysts:
- Café-au-lait spots or neurofibromas for neurofibromatosis.
- Skin rashes or granulomas for sarcoidosis or autoimmune disorders.[68]
- Look for the signs of systemic diseases that may be associated with optic nerve cysts:
Key Points of Differentiation
- Benign cysts:
- Typically present with mild symptoms or are asymptomatic.
- Gradual visual impairment without acute pain.
- Infectious or inflammatory cysts:
- Acute onset of pain, redness, and visual loss.
- Systemic signs of infection or inflammation.
- Neoplastic cysts:
- Progressive proptosis, severe visual field loss, and optic atrophy.
- Associated systemic malignancies or orbital masses.[69]
Importance of History and Physical Examination
A detailed history and physical examination are critical for:
- Establishing the etiology of optic nerve cysts.
- Differentiating it from other orbital or optic nerve pathologies, such as tumors, abscesses, or vascular anomalies.
- Guiding further diagnostic workup, including imaging and laboratory tests.
- Assessing the urgency of intervention based on the severity and progression of symptoms.[70]
Evaluation
Lesions that can be localized through history and physical examination of the optic nerve or brain should be imaged using brain and orbital MRI with and without contrast. Imaging can elucidate the size of the cyst, its consistency, and its effect on surrounding structures. Typically, arachnoid cysts and meningoceles have a signal intensity equal to that of CSF, dark on T1 and bright on T2, without enhancement after intravenous contrast administration.[44]
Optic nerve sheath meningoceles appear as tubular-cystic enlargement of the optic nerve and optic nerve sheath complex on CT and MRI. On coronal MRI, both the optic nerve and sheath appear dilated in a bull's eye pattern. Off-axis sagittal views are the best for showing the widening of the meninges with a fluid-filled space.[44]
In children with microphthalmos, orbital ultrasound should be used to determine the organization of ocular structures. Ultrasound can also be used to visualize cysts in these patients. MRI is more helpful in characterizing the content of the cyst compared to CT, which is typically similar to vitreous or CSF. MRI can also be used to visualize the relationships or connections and communications between the cyst, nerve, and globe. Visual potential in these patients can be evaluated using retinal electrophysiology.[35]
Optic nerve cysts are evaluated using a thorough combination of clinical, radiological, and laboratory investigations. A comprehensive assessment is crucial for accurate diagnosis, differentiation from other orbital or optic nerve pathologies, and formulation of an appropriate management plan.
Clinical Examination
- Visual acuity testing:
- Assess for reduced visual acuity, which is often an early sign of optic nerve involvement.
- Measure near and distance vision to detect subtle changes.
- Pupillary reflex assessment:
- The presence of a relative afferent pupillary defect indicates optic nerve dysfunction.
- Direct and consensual pupillary responses can help identify the degree of optic nerve involvement.
- Ophthalmoscopic examination:
- Papilledema, suggestive of raised intracranial pressure.
- Optic atrophy or pallor, indicating chronic compression.
- Anomalies, such as vascular congestion or hemorrhage.
- Evaluate the optic nerve head for associated fundus changes, such as retinal detachment or choroidal folds.
- Visual field testing:
- Automated perimetry helps detect and quantify visual field defects.
- Depending on the location and size of the cyst, central scotomas, arcuate defects, or generalized field constrictions may be observed.
- Proptosis and ocular alignment:
- Use exophthalmometry to quantify proptosis.
- Assess extraocular movements for restrictions or diplopia.[71]
Imaging Modalities
- Magnetic resonance imaging:
- Identifies the location, size, and extent of the cyst.
- Differentiates between solid and cystic lesions.
- The preferred modality for evaluating optic nerve cysts due to their superior soft-tissue resolution.
- T1- and T2-weighted images can assist in characterizing the cyst. Contrast-enhanced MRI can highlight cyst walls, adjacent inflammation, or compression of surrounding structures.[72]
- Computed tomography:
- Useful in detecting bony remodeling or calcifications associated with the cyst.
- High-resolution CT scans provide detailed orbital anatomy, particularly when evaluating trauma-related cysts or osseous involvement.[73]
- Ultrasound (B-scan):
- Effective for detecting cystic lesions in the retrobulbar space.
- Assesses internal reflectivity to differentiate cystic from solid masses.
- Dynamic scanning may reveal posterior segment involvement or surrounding tissue changes.[74]
- Optical coherence tomography:
- Analyzes the retinal nerve fiber layer and macular thickness.
- Identifies thinning of the retinal nerve fiber layer or macular edema caused by optic nerve compression.[75]
- Angiography:
- Evaluates vascular changes, such as disc leakage, vascular compression, or choroidal abnormalities.
- Used to study choroidal circulation and differentiate inflammatory causes.[76]
- Common forms of angiography include fluorescein angiography and indocyanine green angiography.
Laboratory Investigations
- Blood tests:
- Complete blood count to assess for leukocytosis or eosinophilia.
- Erythrocyte sedimentation rate and C-reactive protein to evaluate inflammation.
- Antinuclear antibodies, rheumatoid factor, or anti-neutrophil cytoplasmic antibodies.
- Serological tests for syphilis, such as rapid plasma reagin and fluorescent treponemal antibody absorption tests; toxoplasmosis; or tuberculosis, such as QuantiFERON Gold test.[77]
- These tests help diagnose inflammatory, autoimmune, or infectious conditions.
- Cerebrospinal fluid analysis:
- Indicates when there is suspicion of raised intracranial pressure or associated central nervous system involvement.
- Helps identify inflammatory, infectious, or neoplastic causes.[78]
- Genetic testing:
- Considered for patients with suspected hereditary conditions, such as neurofibromatosis or familial cystic diseases.[79]
Functional Testing
- Electrophysiological studies:
- Assesses optic nerve conduction and function.
- Delayed responses suggest optic nerve compression or demyelination.[80]
- Used to rule out retinal pathology that may mimic optic nerve involvement.[81]
- Key tests include visual evoked potentials and the electroretinogram.
- Intraocular pressure measurement:
- Elevated intraocular pressure may indicate secondary glaucoma due to cyst-induced compression of the anterior segment or angle.[82]
Histopathological Evaluation
- Indicated for surgically excised lesions or biopsy samples:
- Confirms the diagnosis of optic nerve cysts and rules out neoplastic or infectious conditions.
- Identifies the presence of inflammation, epithelial linings, or specific cystic contents.[83]
National and International Guidelines
- Guidelines emphasize a systematic approach to diagnosing optic nerve cysts:
- Start with noninvasive imaging (MRI or CT).
- Progress to advanced testing, such as optical coherence tomography (OCT) or angiography, for detailed analysis.
- Incorporate laboratory tests based on clinical suspicion of systemic or infectious causes.
- Early referral to an ophthalmologist or neuro-ophthalmologist is crucial for timely diagnosis and management.[84]
A comprehensive evaluation of optic nerve cysts integrates clinical examination, advanced imaging, and laboratory investigations. A multidisciplinary approach ensures accurate diagnosis and aids in planning targeted management, minimizing visual morbidity.
Treatment / Management
Due to the diverse etiologies of optic nerve cysts, treatment approaches are not standardized or well-established in the literature.
The understanding of treatment is mostly based on case studies or case series. The main concern with surgical resection or drainage of these cysts is that it can be associated with significant morbidity due to the risk of optic nerve transection. In addition, surgeons have to ensure that the cyst itself is not a coloboma in an eye with stable vision, as drainage can result in drainage of intraocular contents.
In 1977, Saari et al [85] reported an interesting case of an arachnoid cyst of the intraorbital optic nerve before imaging was available. The patient presented with slight pain in eye movements, transient attacks of blurred vision, optociliary shunt vessels, significant optic disc edema with hemorrhages and macular edema, and shallowing of the anterior chamber, all in the left eye only. The patient had a lumbar puncture with an opening pressure of 150 mm H20. The lesion was believed to be a meningioma. Optic nerve sheath fenestration showed forceful and voluminous egress of CSF. Histopathology of the resected optic nerve sheath was normal. However, 9 months after the procedure, the left eye was blind with significant optic nerve atrophy. The authors recommended prompt diagnosis and drainage of arachnoid cysts to preserve vision.(B3)
Naqvi et al [9] reported 2 cases of optic nerve cysts post-optic nerve sheath fenestration. The patients had loculated CSF surrounded by fibrous proliferation at the previous optic nerve sheath fenestration site. One patient presented with pain, proptosis, and visual loss 9 months after the initial procedure. The other patient presented with vision decline and choroidal folds. Both patients underwent repeat fenestration, during which the closed sheath with fibrosis and outpouching was visualized. Larger windows were created in the sheaths.(B3)
Lunardi et al [21] reviewed 31 cases of optic nerve sheath meningoceles and recommended early surgical management of optic nerve sheath decompression in patients with a rapid decrease in visual acuity over 3 to 6 months. They endorsed the improvement of visual function with minimal morbidity.(B3)
Mehta et al [8] reported a case of neuroepithelial cyst in a 6-week-old patient with proptosis, exotropia, and relative afferent pupillary defect while having a normal anterior and posterior segment ophthalmic examination. The cyst was drained and resected by anterior orbitotomy through an upper eyelid crease incision. The patient's presenting signs, including relative afferent pupillary defect, resolved postoperatively. The authors iterate that the goal of treatment in patients who present with optic nerve cysts is to prevent or reverse vision loss.
Colobomatous cysts can be aspirated if they are cosmetically unacceptable. In many cases, if the cyst returns after repeat aspirations, the eye and cyst may be removed, and the socket may be fitted with prosthetics.[44](B3)
The management of optic nerve cysts is primarily determined by their underlying etiology, size, location, symptoms, and impact on the patient's visual function and overall health. Although many optic nerve cysts remain asymptomatic and are incidentally discovered during imaging, others may present with significant visual or neurological complications that necessitate intervention. The treatment approach requires a multidisciplinary team, including ophthalmologists, neurologists, and neurosurgeons.
Conservative Management
- Conservative management with regular observation is often recommended for asymptomatic or minimally symptomatic optic nerve cysts that do not compromise vision. This approach includes periodic follow-up with clinical examinations and imaging, such as MRI or CT scans, to monitor for size, morphology, or associated structural damage changes.
- Visual field testing should also be conducted periodically to detect early signs of optic nerve dysfunction.[86]
Pharmacological Management
- If inflammation or optic nerve compression is involved, corticosteroids may be prescribed to reduce inflammation and swelling. Immunosuppressive therapy may be considered for autoimmune-related cysts.
- Specific antimicrobial or antiparasitic treatments, such as albendazole or praziquantel for cysticercosis, may be required in cases linked to parasitic or infectious etiologies.[87]
Surgical Management
- Surgical intervention is reserved for symptomatic cysts causing significant optic neuropathy, proptosis, or intracranial complications.
- Depending on the cyst's location and its effect on surrounding tissues, procedures may include cyst aspiration, cyst excision, or optic nerve decompression; minimally invasive techniques, such as endoscopic approaches, are increasingly being used to reduce surgical morbidity.
- In cases of associated intracranial involvement, neurosurgical collaboration is vital to address complications such as hydrocephalus or mass effect on adjacent brain structures.[88] (A1)
Management of Complications
- In patients with raised intracranial pressure due to cyst-related hydrocephalus, ventriculoperitoneal shunting or endoscopic third ventriculostomy may be required.
- Optic nerve sheath fenestration may be considered in cases of progressive visual loss due to increased pressure on the optic nerve.[89]
Rehabilitation and Supportive Care
- For patients with significant visual impairment, low-vision aids and rehabilitation programs can enhance the quality of life.
- Counseling and psychological support may also be necessary for patients with severe visual or neurological symptoms.[90] (A1)
Monitoring and Follow-Up
- Long-term follow-up is essential, particularly in cases with residual cysts, recurrent symptoms, or complex etiologies, such as parasitic or inflammatory causes.
- Repeat imaging and visual assessments ensure early detection of recurrence or progression.[91]
Emerging Therapies
- Advanced imaging and interventional techniques, such as stereotactic surgery and laser-guided interventions, are being explored for the precision management of optic nerve cysts.
- Research into targeted molecular therapies and regenerative treatments holds promise for noninvasive or minimally invasive management in the future.[92] (B3)
Guidelines and Recommendations
- International and national guidelines emphasize individualized care plans based on comprehensive evaluation and interdisciplinary collaboration.
- Patients should be educated about the potential risks of untreated cysts, such as optic neuropathy, and the importance of adhering to follow-up schedules.
The management of optic nerve cysts highlights the importance of balancing effective treatment with preserving vision and minimizing complications. Advances in imaging, surgical techniques, and medical therapies continue to improve outcomes for affected patients.[93][94](A1)
Differential Diagnosis
The differential diagnosis should include optic nerve neoplasms, such as meningiomas and optic nerve gliomas; vascular malformations; and systemic conditions, such as neurofibromatosis and Von Hippel Lindau. Increased CSF pressure due to a cerebral lesion, vascular lesion, or idiopathic intracranial hypertension should be considered, especially if optic nerve sheath dilatation is bilateral.
- Optic nerve glioma: A benign tumor commonly observed in children, associated with NF1, which can cause similar optic nerve swelling and visual symptoms.
- Optic nerve meningioma: A slow-growing tumor arising from the meninges surrounding the optic nerve, leading to gradual visual loss and optic nerve changes.
- Colobomatous cyst: Congenital anomaly often associated with microphthalmia or other eye developmental defects.
- Parasitic cysts: Infections caused by parasitic infections, such as cysticercosis or hydatid cysts, can involve the optic nerve or adjacent structures.
- Arachnoid cyst: Benign, CSF-filled cysts within the arachnoid membrane that may compress the optic nerve if located near it.
- Dermoid or epidermoid cysts: Congenital cystic lesions that may involve the orbit and compress the optic nerve.
- Orbital abscess: Secondary to sinusitis or infection, leading to compression or inflammation around the optic nerve.
- Optic disc drusen: Calcified deposits within the optic nerve head that can mimic cystic changes on imaging.
- Papilledema: Swelling of the optic nerve due to increased intracranial pressure, which can resemble cystic changes on imaging.
- Peripapillary retinal detachment: Detachment of the retina around the optic disc can appear as cystic changes near the optic nerve.
- Inflammatory optic neuropathy (sarcoidosis or multiple sclerosis): Chronic inflammation or demyelination may mimic cystic appearances.
- Optic disc edema due to ischemia (non-arteritic anterior ischemic optic neuropathy or arteritic anterior ischemic optic neuropathy): Vascular causes leading to optic nerve swelling may appear similar to cystic alterations.
- Retinoblastoma: A malignant intraocular tumor in children that may extend to the optic nerve.
- Orbital hemangioma: Vascular malformation within the orbit that may compress or displace the optic nerve.
- Lymphangioma: A vascular lesion in the orbit causing swelling or cyst-like structures around the optic nerve.
- Schwannoma of the optic nerve: A rare tumor arising from Schwann cells, mimicking cystic lesions.
- Craniopharyngioma: A suprasellar tumor that may compress the optic chiasm and mimic cystic optic nerve abnormalities.
- Perineural spread of malignancy: Cyst-like changes can occur when tumors such as squamous cell carcinoma spread along the optic nerve sheath.
- Congenital optic nerve hypoplasia: May present with structural anomalies resembling cystic defects on imaging.
- Glial cysts: Benign cystic changes within the optic nerve due to gliosis or developmental malformations.
Each condition requires a thorough clinical evaluation; imaging studies, such as MRI or CT; and, sometimes, histopathological analysis to effectively differentiate it from optic nerve cysts. Proper identification is critical for tailoring treatment plans and optimizing visual outcomes.
Pertinent Studies and Ongoing Trials
The studies and ongoing trials for optic nerve cysts are currently limited due to the rarity of this condition. However, advances in neuro-ophthalmology, neuroimaging, and minimally invasive techniques have facilitated a better understanding and management of optic nerve cysts. Pertinent studies focus on identifying the pathophysiological basis, optimal imaging modalities, and treatment approaches to ensure effective intervention while preserving visual function.[95]
Pertinent Studies
- Imaging techniques in optic nerve pathology: Numerous retrospective studies have evaluated the role of MRI and OCT in diagnosing and characterizing optic nerve cysts. High-resolution MRI with contrast is particularly effective in distinguishing cysts from other optic nerve lesions, such as gliomas or meningiomas. OCT studies have provided detailed cross-sectional images of optic nerve head morphology, aiding in noninvasive monitoring of cyst progression.[75]
- Role of surgical intervention: Clinical case reports and case series have explored the indications and outcomes of surgical decompression or excision of optic nerve cysts. These studies often highlight the importance of preserving adjacent nerve fibers and minimizing postoperative complications.[96]
- Histopathological analysis: Studies involving the histopathological examination of surgically removed optic nerve cysts, including arachnoid, dermoid, and parasitic cysts, such as those from hydatid disease, have revealed insights into their cellular composition. These findings have contributed to differentiating cyst types and guided targeted treatments.[97]
- Conservative management outcomes: Some longitudinal studies have assessed the outcomes of conservative approaches, such as observation or medical management, particularly in asymptomatic or slow-growing cysts. These studies emphasize the importance of individualized care.
Ongoing Trials
- Noninvasive diagnostic tools: Trials are being conducted to assess the effectiveness of advanced imaging modalities, including ultrahigh-resolution OCT and 3T or 7T MRI, for early detection and detailed characterization of optic nerve cysts.[98]
- Minimally invasive surgery: Investigations into minimally invasive surgical techniques, such as endoscopic or laser-assisted procedures, aim to evaluate their safety and efficacy in removing cysts while preserving optic nerve integrity.[99]
- Pharmacological management: Trials are underway to explore the use of targeted pharmacological agents, including anti-inflammatory drugs and antiparasitic agents, for specific cyst types. For instance, albendazole has been studied in parasitic cysts, such as hydatid disease, that affect the optic nerve.[100]
- Genetic studies: As genetic predispositions are increasingly focused on, some studies are examining genetic markers and mutations associated with congenital optic nerve anomalies, which may include cystic malformations.[101]
Future Directions
- Developing large-scale registries and multicenter collaborations is essential for systematically studying optic nerve cysts and establishing standardized diagnostic and therapeutic protocols.
- Further research into the role of artificial intelligence and machine learning in interpreting imaging data could facilitate early and accurate diagnosis.[6][102][103][104]
- Advances in bioengineering, such as creating artificial optic nerve constructs, are promising ways to address structural defects secondary to cysts.[105]
In summary, although the current literature on optic nerve cysts is limited, ongoing research continues to illuminate innovative diagnostic tools and therapeutic approaches. These efforts aim to improve patient outcomes through early detection, personalized care, and minimally invasive interventions.
Treatment Planning
Treatment for optic nerve cysts requires a multidisciplinary approach tailored to the individual's clinical presentation, the cyst's type, size, location, and potential impact on visual function and neurological health. The primary objective is to preserve vision, mitigate symptoms, and address any underlying pathology contributing to cyst formation.
Evaluation and Assessment
The initial step in treatment involves a thorough clinical and radiological evaluation. A comprehensive ophthalmic examination, including visual acuity, visual field testing, and fundus examination, is critical for assessing the cyst's impact on vision. Advanced imaging techniques, such as high-resolution MRI and OCT, provide detailed insights into the cyst's dimensions, anatomical location, and relationship with adjacent structures. Additional laboratory investigations may be warranted for suspected infectious or inflammatory cysts, including serology and CSF analysis.[106]
Conservative Management
Conservative management with regular monitoring may be appropriate for asymptomatic or small cysts that do not exert significant pressure on the optic nerve or impair vision. Patients should undergo periodic ophthalmic and radiological evaluations to monitor the cyst's size and progression. Any signs of visual deterioration or neurological symptoms require promptly reassessing the treatment plan.[107]
Pharmacological Management
Pharmacological therapies are used for specific types of cysts, such as parasitic cysts, for example, hydatid cysts. Antiparasitic medications, such as albendazole or praziquantel, are administered in conjunction with surgical management or as standalone therapy in certain cases. For inflammatory or autoimmune-related cysts, corticosteroids or immunosuppressive agents may be used to reduce inflammation and prevent further progression.[108]
Surgical Intervention
Surgical intervention is considered for symptomatic cysts, rapid growth, or when conservative measures fail. The choice of surgical approach depends on the cyst's location and accessibility. Microsurgical decompression or excision is commonly used to relieve pressure on the optic nerve and prevent further damage. Endoscopic techniques may be used for cysts located near the anterior visual pathway, minimizing surgical trauma and enhancing recovery.[109]
- Microsurgical excision involves the precise removal of the cyst under high magnification, ensuring that the surrounding optic nerve fibers are preserved.
- Endoscopic surgery is a minimally invasive technique particularly beneficial for cysts located near the optic canal or intracranial segments of the optic nerve, offering access with reduced morbidity.
- Cyst drainage: For cysts that are not amenable to complete excision, aspiration and drainage may be performed to reduce their size and alleviate symptoms.[110]
Postoperative Management
Following surgical intervention, close monitoring is essential to detect any complications, such as recurrence or infection. Postoperative imaging and regular ophthalmic evaluations help ensure the effectiveness of the treatment. Visual therapy may also be recommended to address residual deficits in visual acuity or visual field.[111]
Rehabilitation and Support
Patients with significant visual impairment due to optic nerve cysts may require visual rehabilitation. Low-vision aids, orientation, mobility training, and psychological support are integral to improving the quality of life for affected individuals.[90]
Interdisciplinary Collaboration
Treatment planning for optic nerve cysts often involves collaboration among ophthalmologists, neurologists, neurosurgeons, radiologists, and infectious disease specialists. This interprofessional approach ensures comprehensive care that addresses the condition's ocular and systemic aspects.[112]
Emerging Therapies and Future Directions
Innovative techniques, such as stereotactic radiosurgery, are being explored for the noninvasive management of optic nerve cysts, particularly in cases where surgical access is challenging. Advances in imaging technology and biomarker research may further enhance diagnostic precision and allow for more targeted treatment strategies. In conclusion, treatment planning for optic nerve cysts must be individualized, considering the patient's symptoms, the cyst's characteristics, and the risk-benefit profile of available therapeutic options. Ongoing research and advancements in minimally invasive techniques promise to improve outcomes in this complex and rare condition.[113]
Toxicity and Adverse Effect Management
The management of toxicity and adverse effects in patients with optic nerve cysts mainly focuses on the treatment modalities used and the complications associated with these interventions. These treatments include surgical, pharmacological, or conservative management strategies. A multidisciplinary approach ensures the mitigation of adverse effects and optimal care.[114]
Surgical Toxicity and Complications
Surgical intervention for optic nerve cysts, such as microsurgical excision or endoscopic drainage, poses risks. Potential complications include:
- Optic nerve damage: Incomplete or excessive manipulation during surgery can result in optic nerve injury, leading to visual field defects, reduced visual acuity, or blindness.
- Infection: Postoperative infections, such as meningitis or orbital cellulitis, are rare but serious complications. Prophylactic antibiotics and aseptic techniques are critical in reducing this risk.
- Recurrence: Incomplete cyst excision may lead to recurrence, necessitating additional interventions.
- Hemorrhage: Intraoperative or postoperative bleeding may compress the optic nerve or surrounding structures, impacting visual function.
- Cerebrospinal fluid leak: For cysts near the optic canal or intracranial regions, inadvertent CSF leakage may occur during surgery.[115]
Pharmacological Adverse Effects
Medications used to treat optic nerve cysts, especially in cases of parasitic or inflammatory origins, can cause systemic adverse effects:
- Antiparasitic drugs: Albendazole and praziquantel, commonly used for parasitic cysts, can lead to hepatotoxicity, gastrointestinal discomfort, and allergic reactions. Monitoring liver function tests and assessing patient tolerance are crucial during treatment.[116]
- Corticosteroids: Corticosteroids, commonly used for inflammatory or autoimmune-related cysts, can cause adverse effects such as hyperglycemia, osteoporosis, and immunosuppression. Dose tapering and careful patient monitoring minimize these risks.
- Immunosuppressive agents: These agents may predispose patients to infections or long-term malignancy risks, necessitating vigilant follow-up.[117]
Radiation-Induced Toxicity
Emerging therapies such as stereotactic radiosurgery for optic nerve cysts carry the potential for radiation-induced optic neuropathy. This delayed complication can compromise visual function and requires precise targeting and dose calculation during treatment planning.[118]
Management Strategies for Adverse Effects
- Preoperative planning: Detailed imaging and patient evaluation ensure that the surgical approach minimizes the risk of damage to adjacent structures.
- Prophylaxis: Antibiotics and appropriate pharmacological agents are administered preoperatively to prevent infections.
- Intraoperative monitoring: Advanced intraoperative neurophysiological monitoring helps reduce the risk of optic nerve injury.
- Postoperative care: Regular imaging and clinical assessments post-surgery help detect complications early, enabling timely intervention.
- Pharmacovigilance: Monitoring for drug-induced toxicity involves regular laboratory tests and adjustment of doses as needed.[119]
Long-term Management
Patients undergoing treatment for optic nerve cysts require long-term follow-up to monitor for recurrence, changes in visual function, and delayed adverse effects of therapy. Interdisciplinary collaboration among ophthalmologists, neurologists, and radiologists is critical in ensuring comprehensive care and minimizing treatment-related adverse effects. In conclusion, managing toxicity and adverse effects in optic nerve cysts requires a proactive, patient-centered approach, prioritizing early detection, prevention, and timely intervention to optimize outcomes.[36]
Staging
Staging of optic nerve cysts is not universally standardized due to the rarity of the condition and the variability in clinical presentations. However, a functional and radiological-based staging system can be proposed to assess the severity and guide management.[120]
Proposed Staging Framework for Optic Nerve Cysts
Stage 1: Incidental or asymptomatic cysts
- Clinical features: Patients may be asymptomatic or have vague symptoms, such as mild visual disturbances.
- Imaging findings: Small cysts localized to the optic nerve sheath without compression or optic nerve distortion.
- Management: Observation with periodic imaging and clinical follow-up.[5]
Stage 2: Symptomatic but non-progressive cysts
- Clinical features: Patients present with mild-to-moderate visual field defects, transient visual obscurations, or nonspecific eye discomfort.
- Imaging findings: Cysts causing mild optic nerve compression without significant structural or vascular compromise.
- Management: Conservative treatment, including monitoring visual function and managing symptoms.[56]
Stage 3: Progressive vision impairment
- Clinical features: Patients develop progressive loss of visual acuity, significant visual field defects, or optic disc swelling.
- Imaging findings: Moderate cyst enlargement, with compression and distortion of the optic nerve or associated vasculature.
- Management: Interventional approaches, such as cyst drainage, decompression, or excision, depending on the anatomical involvement.[56]
Stage 4: Advanced or complicated cysts
- Clinical features: Severe vision loss, optic atrophy, or associated complications, such as CSF leakage or intracranial extension.
- Imaging findings: Large, multiloculated cysts with significant optic nerve compression, vascular involvement, or intracranial extension.
- Management: Multidisciplinary approach with surgical intervention and adjunct therapies.[12]
Utility of Staging
The staging system provides a structured approach for clinicians to evaluate and manage optic nerve cysts. This system emphasizes the importance of correlating clinical findings with imaging studies to tailor treatment plans and optimize outcomes. Further research must validate and integrate such a framework into routine clinical practice.
Prognosis
Case reports and case series vary in their outcomes of surgical management compared to observation. Lunardi et al [21] report that 13 out of 33 patients underwent surgical drainage of optic nerve sheath meningoceles, and 5 out of 13 had vision improvement. Although rare, optic nerve cysts vary in size, location, underlying etiology, and associated complications. The outcome is influenced by the degree of optic nerve involvement, the presence of symptoms, and the timeliness of diagnosis and intervention. A detailed understanding of the natural history and potential outcomes is essential to guide management and patient counseling.[36]
Asymptomatic Optic Nerve Cysts
Optic nerve cysts are often incidental, and optical imaging studies are often formed for unrelated reasons. Asymptomatic cysts often remain stable over time and are not associated with progressive vision loss or optic nerve dysfunction. In such cases, the prognosis is excellent, with most patients requiring only periodic observation and no active intervention. Long-term studies have shown that many asymptomatic cysts do not enlarge or cause complications.[5]
Symptomatic Cases
Patients with symptoms such as decreased visual acuity, visual field defects, or ocular pain may have a more guarded prognosis. Symptoms are often due to compression of the optic nerve or its vascular supply. If detected and treated early, the prognosis can be favorable. Timely intervention, such as cyst drainage or decompression, can alleviate symptoms and prevent further visual deterioration. However, delayed diagnosis or inadequate treatment may result in permanent visual impairment.[56]
Progressive or Large Cysts
Large or progressively enlarging cysts that exert significant pressure on the optic nerve or adjacent structures tend to have a poorer prognosis. If left untreated, this compression can result in optic atrophy. These patients are at a high risk of vision loss, even with surgical intervention. Postoperative visual recovery is often incomplete in cases with advanced optic nerve damage.[56]
Complications and Their Impact on Prognosis
Complications, such as intracystic hemorrhage, CSF leakage, or secondary infections, can worsen the prognosis. Intracranial extension of the cyst may further complicate management and carry additional risks, including neurological deficits. The involvement of adjacent structures, such as the chiasm or surrounding brain tissue, may require more extensive surgical procedures, which are associated with a higher risk of complications and less favorable outcomes.[121]
Impact of Treatment on Prognosis
The choice of treatment significantly influences the prognosis. Observation is sufficient for stable, asymptomatic cysts, whereas interventional approaches, such as surgical excision or drainage, are reserved for symptomatic or progressive cases. Advances in minimally invasive surgical techniques, such as endoscopic approaches, have improved outcomes and reduced complications. However, the success of these interventions largely depends on the extent of optic nerve involvement and the skill of the surgical team.[122]
Prognosis in Specific Subtypes
- Congenital cysts: The prognosis is generally favorable if detected. If the symptoms often remain stable without signs, the prognosis is generally favorable for progression.
- Acquired cysts: The prognosis varies widely depending on the underlying causes, such as trauma, infection, or inflammation. Prompt treatment of the primary condition often improves outcomes.
- Cysts associated with systemic conditions: The prognosis is often linked to managing the cysts associated with systemic conditions. For example, cysts associated with neurofibromatosis may have a variable course based on the extent of the disease.[123]
Prognosis and Quality of Life
The overall impact of optic nerve cysts on a patient's quality of life depends on the severity of visual impairment and the presence of associated symptoms. Mild cases with no or minimal symptoms have little to no impact on daily functioning. In contrast, severe cases with significant vision loss or associated complications can substantially affect the patient's ability to perform daily activities, leading to psychological distress and reduced quality of life.[124]
Long-Term Monitoring
Even in cases with successful treatment, long-term follow-up is crucial to monitor for recurrence or progression. Imaging studies, such as MRI or CT scans, and periodic visual function tests, such as visual field analysis and OCT, are essential to ongoing care.[125]
Future Directions
Advancements in imaging technology are expected to improve outcomes. Research into the molecular mechanisms underlying cyst formation and advancements in imaging technologies and surgical techniques may lead to targeted therapies that can prevent progression or recurrence. Personalized treatment plans based on genetic and clinical profiles hold promise for optimizing outcomes in the future.[4]
Summary
The prognosis of optic nerve cysts ranges from excellent in asymptomatic, stable cases to poor in progressive, symptomatic cases with significant optic nerve damage. Early detection, timely intervention, and advances in treatment modalities are crucial in improving outcomes. Long-term monitoring plays a crucial role in ensuring stability and preventing complications, with ongoing research likely to enhance management strategies.
Complications
Optic nerve cysts are rare but can lead to various complications depending on their size, location, and associated pathology. These complications can involve visual, neurological, or systemic effects. Below is a detailed discussion of at least 20 complications associated with optic nerve cysts:
- Visual acuity loss: Compression of the optic nerve fibers can lead to progressive and often irreversible loss of visual acuity, ranging from mild blurring to complete vision loss.
- Visual field defects: Optic nerve cysts can cause specific visual field defects, such as central scotomas, arcuate defects, or peripheral constriction, due to localized nerve fiber compression.
- Optic atrophy: Persistent pressure or ischemia from the cyst may lead to optic atrophy, characterized by pale optic discs and irreversible vision loss.
- Increased intracranial pressure: Large cysts may impede CSF circulation, leading to increased intracranial pressure, which presents as headaches, nausea, vomiting, and papilledema.
- Papilledema: Swelling of the optic disc due to increased intracranial pressure may be associated with optic nerve cysts, especially if they obstruct venous or CSF outflow.
- Cyst rupture: Spontaneous cyst rupture can lead to acute inflammatory responses or infection, which may exacerbate neurological symptoms.
- Cyst hemorrhage: Intracystic bleeding can cause acute worsening of symptoms, including severe headaches, visual impairment, and localized inflammation.
- Hydrocephalus: In cases where the cyst obstructs CSF pathways, hydrocephalus may develop, requiring urgent surgical intervention.
- Retrobulbar pain: Patients may experience significant retrobulbar pain due to the pressure effects of the cyst on surrounding tissues or nerves.
- Diplopia (double vision): Pressure on cranial nerves near the optic nerve can lead to ocular motility dysfunction, resulting in diplopia.
- Strabismus: Misalignment of the eyes may occur due to mechanical displacement or cranial nerve compression caused by the cyst.
- Optic neuritis: Secondary optic nerve inflammation may develop, presenting as pain with eye movement and transient vision loss.
- Retinal detachment: Chronic pressure changes around the optic nerve can alter the vitreoretinal interface, leading to retinal detachment.
- Glaucoma: Cysts that compress the optic nerve or obstruct outflow pathways can cause secondary glaucoma, leading to elevated intraocular pressure and progressive vision loss.
- Neurogenic ocular hypertension: Pressure effects on adjacent nerves may increase intraocular pressure without directly affecting the anterior segment.
- Ischemic optic neuropathy: Compression of the optic nerve's vascular supply can lead to ischemia, manifesting as sudden or gradual vision loss.
- Epileptic seizures: In rare cases where the cyst extends into intracranial regions, seizures may occur due to irritation or compression of adjacent brain structures.
- Headaches and migraines: Chronic pressure from the cyst on surrounding structures can lead to persistent headaches or migraines, especially in cases involving increased intracranial pressure.
- Cerebrospinal fluid leak: Surgical interventions or the spontaneous rupture of a cyst can lead to CSF leaks, which present as clear fluid discharge from the nose or ears and are associated with infection risks.
- Meningitis: Infected optic nerve cysts or associated CSF leaks can lead to bacterial meningitis, characterized by fever, neck stiffness, altered mental status, and significant morbidity.
- Chiasmal compression syndrome: Large cysts that extend toward the optic chiasm may result in bitemporal hemianopia or other complex visual field defects.
- Cranial nerve palsies: Compression of adjacent cranial nerves III, IV, and VI may cause ophthalmoplegia, ptosis, or anisocoria, impacting eye movements and visual alignment.
- Neurological deficits: Large cysts may extend into adjacent brain regions, leading to focal neurological deficits such as motor weakness, sensory changes, or altered cognition.
- Psychological impact: Chronic visual impairment or neurological symptoms may result in anxiety, depression, or diminished quality of life, particularly in younger patients.
- Surgical complications: Treatment interventions, such as cyst excision or drainage, carry risks, such as infection, bleeding, damage to surrounding neural structures, or incomplete cyst removal.
- Recurrent cysts: Post-surgical cyst recurrence can occur, requiring repeated interventions and prolonged follow-up care.
- Secondary tumors or lesions: Optic nerve cysts may rarely be associated with or mimic neoplastic growths, necessitating further diagnostic and therapeutic efforts.
- Fibrosis or adhesions: Chronic inflammation or surgical intervention may lead to fibrosis, which can cause persistent optic nerve dysfunction or limit surgical re-access.
- Intracranial extension: Untreated cysts with aggressive growth may extend intracranially, causing complex neurological symptoms and complicating management.
- Vascular complications: Cysts compressing surrounding vasculature can lead to vascular occlusion, thrombosis, or aneurysms in adjacent vessels.
Conclusion
The complications associated with optic nerve cysts range from mild visual disturbances to severe neurological and systemic effects. Early diagnosis, careful monitoring, and appropriate management are critical to minimizing these complications. Tailored surgical or medical interventions and interprofessional care can improve outcomes and prevent long-term morbidity.
Postoperative and Rehabilitation Care
Postoperative and rehabilitation care for optic nerve cysts is vital in optimizing patient outcomes, preserving visual function, and preventing complications. Post-surgical recovery involves a multidisciplinary approach, including close monitoring, medical therapy, rehabilitation, and patient education.[126]
Immediate Postoperative Care
Immediate postoperative care focuses on managing pain, preventing infection, and minimizing inflammation. Patients are often prescribed topical or systemic corticosteroids to control inflammation and antibiotics to reduce the risk of infection. Analgesics may be recommended to manage pain, and anti-glaucoma medications may be required if intraocular pressure increases. A sterile environment and adherence to aseptic techniques during dressing changes are essential.[127]
Monitoring Visual Function
Monitoring visual function is critical in the early recovery phase. Comprehensive ophthalmic evaluations, including visual acuity testing, visual field analysis, and fundoscopic examination, are performed periodically to assess the effectiveness of the surgery and detect any signs of recurrence or complications, such as optic atrophy or nerve damage.[128]
Follow-Up Imaging Studies
Follow-up imaging studies, such as MRI or CT scans, are performed to confirm complete cyst removal and monitor for any residual or recurrent cystic structures. Imaging also helps identify any secondary structural changes, such as fibrosis or adhesion formation, which may impact visual or neurological function.[129]
Management of Postoperative Complications
The management of postoperative complications involves addressing issues such as increased intracranial pressure, CSF leaks, or secondary glaucoma. If complications arise, prompt surgical or medical interventions are necessary. For example, CSF leaks may require lumbar drainage or repair, whereas glaucoma is treated with medications or surgical procedures such as trabeculectomy.[130]
Vision Rehabilitation
Vision rehabilitation is integral for patients who experience residual visual deficits after surgery. Low-vision aids such as magnifiers and electronic devices can help improve functional vision. Occupational therapy may be recommended to enhance daily living skills, and counseling support can address the emotional and psychological impact of vision loss.[90]
Physical and Neurological Rehabilitation
Physical and neurological rehabilitation is essential for patients with associated neurological deficits. Neuro-ophthalmologists and neurologists collaborate to provide targeted therapies, such as physical therapy for motor impairments or cognitive therapy for memory and concentration issues.[131]
Patient Education and Counseling
Patient education and counseling are vital components of postoperative care. Patients and caregivers should be educated about recognizing signs of recurrence, the importance of medication adherence, and the need for regular follow-ups. Counseling sessions can help patients cope with the psychological impact of living with potential visual impairments or other neurological sequelae.[132]
Long-Term Follow-Up
Long-term follow-up involves ongoing ophthalmologic and neurologic assessments to detect late complications, such as optic neuropathy, cyst recurrence, or chronic inflammation. Periodic imaging and functional evaluations ensure that any issues are promptly addressed.[133]
In conclusion, postoperative and rehabilitation care for optic nerve cysts requires a holistic approach that encompasses medical management, functional recovery, and psychosocial support. The active involvement of an interprofessional team, including ophthalmologists, neurologists, rehabilitation specialists, and counselors, ensures comprehensive care tailored to each patient's needs.
Consultations
The management of optic nerve cysts requires a collaborative and multidisciplinary approach to ensure accurate diagnosis, comprehensive treatment, and effective long-term care. Consultations with various specialties are crucial for addressing the diverse clinical implications of this condition.[134]
Neuro-Ophthalmology Consultation
Neuroophthalmologists play a central role in evaluating and managing optic nerve cysts. These specialists conduct detailed assessments of visual function, including visual acuity, visual fields, and optic nerve integrity, while coordinating advanced imaging studies, such as OCT, MRI, or CT, to determine the size, location, and impact of the cyst on surrounding structures.[135]
Neurology Consultation
Neurologists assess and manage any associated neurological symptoms or conditions, such as headaches, seizures, or elevated intracranial pressure, which can arise due to optic nerve cysts. Neurological evaluations are essential for identifying broader systemic implications, including potential underlying disorders, such as neurofibromatosis or intracranial masses.[135]
Radiology Consultation
Radiologists are critical in interpreting imaging studies, helping to differentiate optic nerve cysts from other orbital or intracranial lesions. Their expertise ensures precise localization and characterization of the cyst, providing valuable information for surgical planning or monitoring disease progression.[45]
Oculoplastic and Orbital Surgery Consultation
When surgical intervention is necessary, consultation with oculoplastic orbital surgeons is vital. These specialists are equipped to perform intricate procedures to drain, excise, or decompress the cyst while minimizing damage to surrounding ocular and orbital structures.[136]
Oncology Consultation
When nerve cysts are associated with neoplastic processes, such as optic nerve gliomas or meningiomas. Consultation with an oncologist is essential. Oncologists guide the management of these conditions through chemotherapy, radiation, or other targeted therapies as needed.[137]
Endocrinology Consultation
Endocrinologists provide insights into hormonal imbalances and recommend appropriate medical management or replacement therapy for patients with optic nerve cysts linked to systemic conditions, such as hypothalamic dysfunction or pituitary tumors.[138]
Genetics Consultation
Geneticists may be involved if optic nerve cysts are associated with hereditary syndromes, such as NF1 or other familial conditions. Genetic counseling can inform patients and families about inheritance patterns, risks, and screening recommendations.[139]
Pediatric Consultation
Early diagnosis and intervention are crucial in pediatric patients. Pediatricians and pediatric ophthalmologists collaborate to monitor growth and development, ensuring optimal visual and neurological outcomes.[140]
Pain Management Consultation
For patients experiencing chronic pain or discomfort related to optic nerve cysts, a pain management specialist can offer strategies to alleviate symptoms using medications, nerve blocks, or other interventions.[141]
Rehabilitation Consultation
Low-vision specialists and rehabilitation therapists help patients adapt to visual impairments caused by optic nerve cysts. They provide training on using assistive devices, mobility aids, and strategies for maintaining independence in daily activities.[90]
Psychology or Psychiatry Consultation
Coping with visual impairment or neurological complications can have a significant psychological impact. Consultation with a psychologist or psychiatrist is essential for addressing anxiety, depression, or adjustment disorders and offering counseling and emotional support to patients and their families.[142]
Primary Care Physician Coordination
Primary care physicians are central in coordinating care, ensuring timely referrals, and monitoring the patient's overall health, including any systemic conditions that may influence the course of optic nerve cysts.[134]
In conclusion, a multidisciplinary consultation framework enhances the diagnostic accuracy, treatment outcomes, and quality of life for patients with optic nerve cysts. Timely collaboration among specialists ensures that all aspects of the condition, including its ocular, neurological, and systemic impacts, are effectively addressed.
Deterrence and Patient Education
Deterrence and patient education are pivotal in effectively managing and preventing complications associated with optic nerve cysts. Although the development of optic nerve cysts cannot always be prevented due to their association with congenital or idiopathic factors, proactive strategies and patient education can minimize the risks of misdiagnosis, delayed treatment, or unnecessary interventions.[13]
Awareness and Early Detection
Early detection requires educating patients and healthcare professionals about the signs and symptoms of optic nerve cysts, such as progressive vision loss, visual field defects, or ocular discomfort. This education is critical for individuals at higher risk, such as those with a family history of ocular or neurological disorders.[143]
Regular Eye Examinations
Routine ophthalmic evaluations, including dilated fundus examinations, can help identify optic nerve abnormalities in a timely manner. Patients, particularly those with predisposing conditions such as neurofibromatosis, should be encouraged to attend regular check-ups.[144]
Understanding the Condition
Providing patients with comprehensive information about optic nerve cysts, including their benign nature in many cases and potential complications, can alleviate anxiety and encourage adherence to follow-up care. Visual aids, brochures, and digital resources can enhance patient understanding.[132]
Collaborative Care
Encouraging a multidisciplinary approach ensures comprehensive management. Patients should be informed about the roles of different specialists, such as neuro-ophthalmologists, radiologists, and neurosurgeons, in their care journey.[145]
Preventing Secondary Complications
Educating patients about the importance of monitoring symptoms, such as sudden vision changes, headaches, or neurological signs, can lead to early intervention and prevent complications, such as optic neuropathy or raised intracranial pressure.[146]
Rehabilitation and Coping Strategies
For patients experiencing visual impairment, education about low-vision aids, rehabilitation services, and lifestyle adjustments can significantly improve their quality of life. Support groups or counseling services may also be beneficial.[90]
Genetic Counseling
In cases linked to hereditary syndromes, patients and their families should be educated about the importance of genetic counseling. This education can provide insight into recurrence risks, screening recommendations, and implications for family planning.[147]
Medication and Treatment Compliance
If pharmacological interventions, such as corticosteroids for associated inflammation, are part of the management plan, educating patients about the importance of compliance and potential adverse effects is critical. Clear instructions on medication use and monitoring are also necessary.[132]
Avoiding Unnecessary Interventions
Patients should be counseled about the importance of evidence-based decision-making. Avoiding unnecessary surgical or invasive procedures is vital, especially for asymptomatic or stable cysts, where observation may be the most appropriate approach.[148]
Empowerment Through Knowledge
Ultimately, empowering patients with knowledge fosters shared decision-making and promotes better healthcare outcomes. Well-informed patients are more likely to recognize symptoms early, seek timely care, and actively participate in treatment plans.[149]
By integrating these deterrence and education strategies, healthcare professionals can enhance patient outcomes, reduce complications, and promote a more patient-centered approach to managing optic nerve cysts.
Pearls and Other Issues
Although rare, optic nerve cysts pose a significant diagnostic and management challenge in neuro-ophthalmology. A thorough understanding of their clinical presentation, diagnostic nuances, and treatment implications is critical for healthcare professionals. These cysts are often asymptomatic and discovered incidentally, but they may sometimes present with vision-related symptoms or complications, such as optic nerve compression or neurological deficits. Recognizing the subtle signs and correlating them with imaging findings are essential to prevent misdiagnosis and inappropriate management.[36]
Diagnostic Pearls
- Imaging as a key tool: MRI is the diagnostic modality of choice for optic nerve cysts. A high-resolution scan helps delineate the cystic structure and its relationship with the optic nerve and adjacent tissues.
- Differentiation from other lesions: Differentiating from other conditions, such as optic nerve gliomas, meningiomas, or inflammatory demyelinating lesions, is crucial. A comprehensive review of imaging features and clinical findings is needed.
- Symptom evaluation: Optic nerve cysts can occasionally cause visual field defects, decreased visual acuity, or optic disc swelling. These symptoms must be evaluated in the context of other systemic or neurological findings.[150]
Management Insights
- Observation: Asymptomatic optic nerve cysts with no evidence of optic nerve compression can often be monitored without immediate intervention. Regular follow-ups with imaging and visual function tests are recommended.
- Surgical intervention: Symptomatic cysts causing visual impairment or compression of the optic nerve may require surgical drainage or decompression. The decision for surgery must balance the risks and potential benefits.
- Multidisciplinary approach: Given the proximity to critical neurovascular structures, collaboration among ophthalmologists, neurologists, and neurosurgeons is essential for optimal outcomes.[151]
Prevention of Mismanagement
A significant issue in managing optic nerve cysts is the potential for overtreatment or misdiagnosis. Misinterpreting imaging findings or failing to recognize the benign nature of many cysts can lead to unnecessary invasive procedures. Patient education about the condition's benign nature in most cases is crucial for alleviating anxiety and ensuring adherence to follow-up.[152]
Clinical Challenges
- Rare presentation: Optic nerve cysts are infrequently encountered, leading to potential under-recognition among clinicians unfamiliar with their features.
- Overlap with other pathologies: Conditions such as arachnoid cysts, inflammatory lesions, and neoplastic conditions can mimic optic nerve cysts, necessitating a careful diagnostic approach.
- Progression monitoring: Although most cysts remain stable, a small proportion may enlarge or become symptomatic, highlighting the importance of vigilant monitoring.[5]
Educational Points for Healthcare Professionals
- Awareness and training: Enhanced training in neuro-ophthalmology can help clinicians better recognize and manage rare conditions such as optic nerve cysts.
- Interprofessional collaboration: Effective communication among specialties is essential for achieving optimal outcomes in complex cases.
- Evidence-based practices: Staying updated with emerging research and case studies on optic nerve cysts helps refine management strategies and improve patient care.[153]
Future Directions
As imaging technologies and surgical techniques continue to advance, the understanding and management of optic nerve cysts improve. The role of minimally invasive procedures and improved diagnostic tools may reduce the burden of invasive surgeries while ensuring precise diagnosis. Future studies are needed to establish standardized protocols for monitoring and managing these cysts, particularly in asymptomatic cases.
Optic nerve cysts require a nuanced approach to diagnosis and management, with careful evaluation to prevent unnecessary interventions. By incorporating a multidisciplinary approach and leveraging advancements in imaging and surgical techniques, healthcare professionals can effectively address the challenges associated with this condition.[92]
Enhancing Healthcare Team Outcomes
Orbital pain, vision loss, and proptosis are symptoms that patients may present to primary care physicians or general ophthalmologists before being referred to oculoplastics surgeons, neuro-ophthalmologists, or neurosurgeons. Pediatricians, internal medicine specialists, and family physicians should know the risk of vision loss if a referral is delayed. Imaging of the orbits and brain is appropriate before referral. In addition, oculoplastic surgeons, neuro-ophthalmologists, and neurosurgeons may need to collaborate to monitor patients after surgery for a lesion recurrence.
The management of optic nerve cysts necessitates an interdisciplinary approach, as these rare entities often involve overlapping domains of ophthalmology, neurology, radiology, and, sometimes, neurosurgery. Collaborative teamwork ensures a comprehensive evaluation and tailored management strategy, optimizing patient care while minimizing unnecessary interventions.[65]
Role of Interprofessional Collaboration
Healthcare teams managing optic nerve cysts consist of ophthalmologists, neuro-ophthalmologists, radiologists, and, in some cases, neurosurgeons. Effective collaboration begins with prompt referral and thorough diagnostic evaluations. Ophthalmologists play a pivotal role in initial assessment, identifying visual symptoms and correlating them with fundoscopic findings. Neuro-ophthalmologists provide expertise in understanding the neurological implications and ensuring differential diagnoses. Radiologists are crucial for interpreting advanced imaging modalities, such as MRI and CT, which provide detailed structural information about the cysts. Neurosurgeons, when required, intervene surgically to manage symptomatic cysts causing optic nerve compression or neurological deficits.[154]
Effective Communication and Coordination
Clear and timely communication among team members is essential for seamless care delivery. Structured referral systems, shared electronic health records, and regular case discussions enhance information exchange and reduce mismanagement risks. Multidisciplinary team meetings can be particularly effective in complex or ambiguous cases, ensuring that all perspectives are considered before proceeding with treatment.[155]
Patient-Centered Care
Focusing on patient-centered care is a key component of enhancing healthcare team outcomes. Educating patients about the benign nature of many optic nerve cysts and the necessity for regular follow-ups fosters trust and compliance. A clear understanding of treatment options, including observation versus surgical intervention, empowers patients to make informed decisions in collaboration with their care team.[156]
Skill Development and Training
Continuous professional development is vital for all team members to remain updated on the latest diagnostic and management protocols for optic nerve cysts. Training programs highlighting the nuances of imaging interpretation, surgical techniques, and patient communication can significantly enhance team competence and confidence.[157]
Ethical and Strategic Considerations
Ethical considerations, such as avoiding overtreatment of asymptomatic cysts, must guide decision-making processes. Strategies for standardized care pathways help reduce variability in practice and ensure adherence to evidence-based guidelines. These pathways must be dynamic, integrating emerging research findings to reflect the latest standards of care.[158]
Impact on Outcomes
An interprofessional approach improves diagnostic accuracy, ensures timely management of symptomatic cases, and minimizes complications. By leveraging the expertise of diverse specialists, healthcare teams can enhance visual and neurological outcomes while reducing the psychological burden on patients. This collaborative effort ultimately elevates the quality of care, ensuring that patients with optic nerve cysts receive the best possible treatment tailored to their needs.
In conclusion, the effective management of optic nerve cysts requires a cohesive, interprofessional healthcare team that prioritizes communication, collaboration, and patient-centered strategies. By adopting these principles, teams can significantly improve clinical outcomes, patient satisfaction, and overall care delivery.[159]
References
Goel N. Optic Nerve Cysticercosis at the Orbital Apex Presenting as Optic Neuritis. Journal of ophthalmic & vision research. 2018 Oct-Dec:13(4):508-510. doi: 10.4103/jovr.jovr_251_16. Epub [PubMed PMID: 30479724]
Akor C, Wojno TH, Newman NJ, Grossniklaus HE. Arachnoid cyst of the optic nerve: report of two cases and review of the literature. Ophthalmic plastic and reconstructive surgery. 2003 Nov:19(6):466-9 [PubMed PMID: 14625493]
Level 3 (low-level) evidenceChandra S, Vashisht S, Menon V, Berry M, Mukherji SK. Optic nerve cysticercosis: imaging findings. AJNR. American journal of neuroradiology. 2000 Jan:21(1):198-200 [PubMed PMID: 10669250]
Hussain S, Mubeen I, Ullah N, Shah SSUD, Khan BA, Zahoor M, Ullah R, Khan FA, Sultan MA. Modern Diagnostic Imaging Technique Applications and Risk Factors in the Medical Field: A Review. BioMed research international. 2022:2022():5164970. doi: 10.1155/2022/5164970. Epub 2022 Jun 6 [PubMed PMID: 35707373]
Touarsa F, El Ouali I, Elkettani N, Fikri M, Jiddane M. Incidental optic nerve sheath arachnoid cyst: A rare case finding with literature review. SAGE open medical case reports. 2022:10():2050313X221113261. doi: 10.1177/2050313X221113261. Epub 2022 Jul 22 [PubMed PMID: 35899247]
Level 3 (low-level) evidenceMurugan SRB, Sanjay S, Somanath A, Mahendradas P, Patil A, Kaur K, Gurnani B. Artificial Intelligence in Uveitis: Innovations in Diagnosis and Therapeutic Strategies. Clinical ophthalmology (Auckland, N.Z.). 2024:18():3753-3766. doi: 10.2147/OPTH.S495307. Epub 2024 Dec 14 [PubMed PMID: 39703602]
Kaur K, Gurnani B, Devy N. Atypical optic neuritis - a case with a new surprise every visit. GMS ophthalmology cases. 2020:10():Doc11. doi: 10.3205/oc000138. Epub 2020 Feb 27 [PubMed PMID: 32269909]
Level 3 (low-level) evidenceMehta VJ, Chelnis JG, Nickols HH, Mawn LA. Neuroepithelial Cyst of the Optic Nerve in a Newborn. Ophthalmic plastic and reconstructive surgery. 2017 May/Jun:33(3S Suppl 1):S109-S111. doi: 10.1097/IOP.0000000000000653. Epub [PubMed PMID: 27438808]
Naqvi SM, Thiagarajah C, Golnik K, Lee A, Kersten R, Nerad J. Optic nerve cyst-like formation presenting as a delayed complication of optic nerve sheath fenestration. Ophthalmic plastic and reconstructive surgery. 2014 May-Jun:30(3):e53-4. doi: 10.1097/IOP.0b013e31829bb3e8. Epub [PubMed PMID: 23880976]
Level 3 (low-level) evidenceMustansir F, Bashir S, Darbar A. Management of Arachnoid Cysts: A Comprehensive Review. Cureus. 2018 Apr 10:10(4):e2458. doi: 10.7759/cureus.2458. Epub 2018 Apr 10 [PubMed PMID: 29888162]
Kural C, Kullmann M, Weichselbaum A, Schuhmann MU. Congenital left temporal large arachnoid cyst causing intraorbital optic nerve damage in the second decade of life. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 2016 Mar:32(3):575-8. doi: 10.1007/s00381-015-2859-3. Epub 2015 Aug 9 [PubMed PMID: 26255149]
Khalili N, Iranpour P, Khalili N, Haseli S. Hydatid Disease: A Pictorial Review of Uncommon Locations. Iranian journal of medical sciences. 2023 Mar:48(2):118-129. doi: 10.30476/IJMS.2022.93123.2442. Epub [PubMed PMID: 36895460]
Mcnab AA, Wright JE. Cysts of the optic nerve three cases associated with meningioma. Eye (London, England). 1989:3 ( Pt 3)():355-9 [PubMed PMID: 2612682]
Level 3 (low-level) evidenceYeşiltaş YS, Gündüz AK. Idiopathic Orbital Inflammation: Review of Literature and New Advances. Middle East African journal of ophthalmology. 2018 Apr-Jun:25(2):71-80. doi: 10.4103/meajo.MEAJO_44_18. Epub [PubMed PMID: 30122852]
Level 3 (low-level) evidenceSheikh AM, Yano S, Tabassum S, Nagai A. The Role of the Vascular System in Degenerative Diseases: Mechanisms and Implications. International journal of molecular sciences. 2024 Feb 11:25(4):. doi: 10.3390/ijms25042169. Epub 2024 Feb 11 [PubMed PMID: 38396849]
Aizawa R, Uto M, Takehana K, Arakawa Y, Miyamoto S, Mizowaki T. Radiation-induced cystic brain necrosis developing 10 years after linac-based stereotactic radiosurgery for brain metastasis. Oxford medical case reports. 2018 Nov:2018(11):omy090. doi: 10.1093/omcr/omy090. Epub 2018 Oct 17 [PubMed PMID: 30364384]
Level 3 (low-level) evidenceCampen CJ, Gutmann DH. Optic Pathway Gliomas in Neurofibromatosis Type 1. Journal of child neurology. 2018 Jan:33(1):73-81. doi: 10.1177/0883073817739509. Epub [PubMed PMID: 29246098]
Johnson MW. Perifoveal vitreous detachment and its macular complications. Transactions of the American Ophthalmological Society. 2005:103():537-67 [PubMed PMID: 17057817]
Level 2 (mid-level) evidenceSfiniadaki E,Tsiara I,Theodossiadis P,Chatziralli I, Ocular Manifestations of Granulomatosis with Polyangiitis: A Review of the Literature. Ophthalmology and therapy. 2019 Jun; [PubMed PMID: 30875067]
Amador-Patarroyo MJ, Pérez-Rueda MA, Tellez CH. Congenital anomalies of the optic nerve. Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. 2015 Jan-Mar:29(1):32-8. doi: 10.1016/j.sjopt.2014.09.011. Epub 2014 Sep 28 [PubMed PMID: 25859137]
Lunardi P, Farah JO, Ruggeri A, Nardacci B, Ferrante L, Puzzilli F. Surgically verified case of optic sheath nerve meningocele: case report with review of the literature. Neurosurgical review. 1997:20(3):201-5 [PubMed PMID: 9297723]
Level 3 (low-level) evidenceRao AA, Naheedy JH, Chen JY, Robbins SL, Ramkumar HL. A clinical update and radiologic review of pediatric orbital and ocular tumors. Journal of oncology. 2013:2013():975908. doi: 10.1155/2013/975908. Epub 2013 Mar 12 [PubMed PMID: 23577029]
Laasri K, El Harras Y, Izi Z, El Yousfi Z, El Fenni J, En Nafaa I. Congenital right optic nerve colobomatous cyst associated with microphthalmos. Radiology case reports. 2024 Nov:19(11):5346-5349. doi: 10.1016/j.radcr.2024.07.186. Epub 2024 Aug 28 [PubMed PMID: 39280748]
Level 3 (low-level) evidenceDiggs-Andrews KA, Brown JA, Gianino SM, Rubin JB, Wozniak DF, Gutmann DH. Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1. Annals of neurology. 2014 Feb:75(2):309-16. doi: 10.1002/ana.24093. Epub 2014 Feb 6 [PubMed PMID: 24375753]
Carpio A, Romo ML, Parkhouse RM, Short B, Dua T. Parasitic diseases of the central nervous system: lessons for clinicians and policy makers. Expert review of neurotherapeutics. 2016:16(4):401-14. doi: 10.1586/14737175.2016.1155454. Epub 2016 Mar 4 [PubMed PMID: 26894629]
Van Stavern GP. Metabolic, hereditary, traumatic, and neoplastic optic neuropathies. Continuum (Minneapolis, Minn.). 2014 Aug:20(4 Neuro-ophthalmology):877-906. doi: 10.1212/01.CON.0000453313.37143.9b. Epub [PubMed PMID: 25099099]
Gurnani B, Kaur K, Sekaran S. First case of coloboma, lens neovascularization, traumatic cataract, and retinal detachment in a young Asian female. Clinical case reports. 2021 Sep:9(9):e04743. doi: 10.1002/ccr3.4743. Epub 2021 Aug 30 [PubMed PMID: 34484773]
Level 3 (low-level) evidenceCassina M, Frizziero L, Opocher E, Parrozzani R, Sorrentino U, Viscardi E, Miglionico G, Midena E, Clementi M, Trevisson E. Optic Pathway Glioma in Type 1 Neurofibromatosis: Review of Its Pathogenesis, Diagnostic Assessment, and Treatment Recommendations. Cancers. 2019 Nov 14:11(11):. doi: 10.3390/cancers11111790. Epub 2019 Nov 14 [PubMed PMID: 31739524]
Del Brutto OH. Human Neurocysticercosis: An Overview. Pathogens (Basel, Switzerland). 2022 Oct 20:11(10):. doi: 10.3390/pathogens11101212. Epub 2022 Oct 20 [PubMed PMID: 36297269]
Level 3 (low-level) evidenceGuarnera A, Valente P, Pasquini L, Moltoni G, Randisi F, Carducci C, Carboni A, Lucignani G, Napolitano A, Romanzo A, Longo D, Gandolfo C, Rossi-Espagnet MC. Congenital Malformations of the Eye: A Pictorial Review and Clinico-Radiological Correlations. Journal of ophthalmology. 2024:2024():5993083. doi: 10.1155/2024/5993083. Epub 2024 Jan 30 [PubMed PMID: 38322500]
Okoye GS, Gurnani B. Traumatic Cataract. StatPearls. 2025 Jan:(): [PubMed PMID: 37603642]
Gurnani B, Christy J, Narayana S, Rajkumar P, Kaur K, Gubert J. Retrospective multifactorial analysis of Pythium keratitis and review of literature. Indian journal of ophthalmology. 2021 May:69(5):1095-1101. doi: 10.4103/ijo.IJO_1808_20. Epub [PubMed PMID: 33913840]
Level 2 (mid-level) evidenceGurnani B, Kaur K. Ocular Surface Squamous Neoplasia. StatPearls. 2025 Jan:(): [PubMed PMID: 34424655]
Schnider C, Yuen L, Rampat R, Zhu D, Dhallu S, Trinh T, Gurnani B, Abdelmaksoud A, Bhogal-Bhamra G, Wolffsohn JS, Naroo SA. BCLA CLEAR presbyopia: Management with intraocular lenses. Contact lens & anterior eye : the journal of the British Contact Lens Association. 2024 Aug:47(4):102253. doi: 10.1016/j.clae.2024.102253. Epub 2024 Jul 2 [PubMed PMID: 39068141]
Slamovits TL, Kimball GP, Friberg TR, Curtin HD. Bilateral optic disc colobomas with orbital cysts and hypoplastic optic nerves and chiasm. Journal of clinical neuro-ophthalmology. 1989 Sep:9(3):172-7 [PubMed PMID: 2529276]
Level 3 (low-level) evidenceSolli E, Turbin RE. Primary and Secondary Optic Nerve Sheath Meningioma. Journal of neurological surgery. Part B, Skull base. 2021 Feb:82(1):27-71. doi: 10.1055/s-0041-1723801. Epub 2021 Feb 18 [PubMed PMID: 33777618]
Khullar S, Ambiya V, Kapoor G, Sharma VK. Myriad of congenital excavated optic disc anomalies in achondroplasia. BMJ case reports. 2024 Nov 20:17(11):. pii: e261738. doi: 10.1136/bcr-2024-261738. Epub 2024 Nov 20 [PubMed PMID: 39572068]
Level 3 (low-level) evidenceWang J, Hamm RJ, Povlishock JT. Traumatic axonal injury in the optic nerve: evidence for axonal swelling, disconnection, dieback, and reorganization. Journal of neurotrauma. 2011 Jul:28(7):1185-98. doi: 10.1089/neu.2011.1756. Epub 2011 Jul 12 [PubMed PMID: 21506725]
Razek AA, Castillo M. Imaging lesions of the cavernous sinus. AJNR. American journal of neuroradiology. 2009 Mar:30(3):444-52. doi: 10.3174/ajnr.A1398. Epub 2008 Dec 18 [PubMed PMID: 19095789]
Kessel L, Hamann S, Wegener M, Tong J, Fraser CL. Microcystic macular oedema in optic neuropathy: case series and literature review. Clinical & experimental ophthalmology. 2018 Dec:46(9):1075-1086. doi: 10.1111/ceo.13327. Epub 2018 Jun 20 [PubMed PMID: 29799159]
Level 2 (mid-level) evidenceWhite ML, Das JM. Arachnoid Cysts. StatPearls. 2025 Jan:(): [PubMed PMID: 33085419]
Weber AJ, Harman CD, Viswanathan S. Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina. The Journal of physiology. 2008 Sep 15:586(18):4393-400. doi: 10.1113/jphysiol.2008.156729. Epub 2008 Jun 19 [PubMed PMID: 18565994]
Wynn TA. Cellular and molecular mechanisms of fibrosis. The Journal of pathology. 2008 Jan:214(2):199-210 [PubMed PMID: 18161745]
Shields JA, Shields CL. Orbital cysts of childhood--classification, clinical features, and management. Survey of ophthalmology. 2004 May-Jun:49(3):281-99 [PubMed PMID: 15110666]
Level 3 (low-level) evidenceVogele D, Sollmann N, Beck A, Haggenmüller B, Schmidt SA, Schmitz B, Kapapa T, Ozpeynirci Y, Beer M, Kloth C. Orbital Tumors-Clinical, Radiologic and Histopathologic Correlation. Diagnostics (Basel, Switzerland). 2022 Sep 30:12(10):. doi: 10.3390/diagnostics12102376. Epub 2022 Sep 30 [PubMed PMID: 36292065]
Benson JC, Giannini C, Cohen Cohen S, Van Gompel J, Kim DK, Port J, Diehn F, Eckel L, Carr C. Optic Nerve Choristoma Mimicking a Neurenteric Cyst. AJNR. American journal of neuroradiology. 2021 Jan:42(2):228-232. doi: 10.3174/ajnr.A6892. Epub 2020 Dec 10 [PubMed PMID: 33303524]
Polito E, Leccisotti A. Colobomatous ocular cyst excision with globe preservation. Ophthalmic plastic and reconstructive surgery. 1995 Dec:11(4):288-92 [PubMed PMID: 8746823]
Aprile I, Iaiza F, Lavaroni A, Budai R, Dolso P, Scott CA, Beltrami CA, Fabris G. Analysis of cystic intracranial lesions performed with fluid-attenuated inversion recovery MR imaging. AJNR. American journal of neuroradiology. 1999 Aug:20(7):1259-67 [PubMed PMID: 10472983]
Burda JE, Sofroniew MV. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron. 2014 Jan 22:81(2):229-48. doi: 10.1016/j.neuron.2013.12.034. Epub [PubMed PMID: 24462092]
Ramos MF, Baker J, Atzpodien EA, Bach U, Brassard J, Cartwright J, Farman C, Fishman C, Jacobsen M, Junker-Walker U, Kuper F, Moreno MCR, Rittinghausen S, Schafer K, Tanaka K, Teixeira L, Yoshizawa K, Zhang H. Nonproliferative and Proliferative Lesions of the Ratand Mouse Special Sense Organs(Ocular [eye and glands], Olfactory and Otic). Journal of toxicologic pathology. 2018:31(3 Suppl):97S-214S. doi: 10.1293/tox.31.97S. Epub 2018 Jul 28 [PubMed PMID: 30158741]
McLendon RE, Bigner DD. Immunohistochemistry of the glial fibrillary acidic protein: basic and applied considerations. Brain pathology (Zurich, Switzerland). 1994 Jul:4(3):221-8 [PubMed PMID: 7952263]
Tarlov IM. Spinal perineurial and meningeal cysts. Journal of neurology, neurosurgery, and psychiatry. 1970 Dec:33(6):833-43 [PubMed PMID: 5531903]
Yun HJ, Kim JH, Woo KI, Kim YD. Correlation Between Radiologic and Histopathologic Features of Orbital Epidermoid and Dermoid Cysts. Ophthalmic plastic and reconstructive surgery. 2024 Jul-Aug 01:40(4):411-415. doi: 10.1097/IOP.0000000000002602. Epub 2024 Jan 25 [PubMed PMID: 38285927]
Abusayf MM, Alkatan HM, Elkhamary S, Almesfer SA, Maktabi AMY. Histopathological assessment of optic nerve invasion guided by radiological findings in enucleated globes with retinoblastoma. BMC ophthalmology. 2020 Sep 29:20(1):386. doi: 10.1186/s12886-020-01654-z. Epub 2020 Sep 29 [PubMed PMID: 32993566]
Garrity JA, Trautmann JC, Bartley GB, Forbes G, Bullock JD, Jones TW Jr, Waller RR. Optic nerve sheath meningoceles. Clinical and radiographic features in 13 cases with a review of the literature. Ophthalmology. 1990 Nov:97(11):1519-31 [PubMed PMID: 2255524]
Level 3 (low-level) evidenceNewman N, Biousse V. Diagnostic approach to vision loss. Continuum (Minneapolis, Minn.). 2014 Aug:20(4 Neuro-ophthalmology):785-815. doi: 10.1212/01.CON.0000453317.67637.46. Epub [PubMed PMID: 25099095]
Level 3 (low-level) evidenceBalamurugan S, Kaur K, Gurnani B, Agrawal A. Bilateral acute vision loss as the initial presentation of chronic myeloid leukemia in a young female. Indian journal of cancer. 2023 Oct 1:60(4):578-582. doi: 10.4103/ijc.ijc_573_21. Epub 2024 Jan 9 [PubMed PMID: 38206079]
Chen S, Zeng L, Hu Z. Progressing haemorrhagic stroke: categories, causes, mechanisms and managements. Journal of neurology. 2014 Nov:261(11):2061-78. doi: 10.1007/s00415-014-7291-1. Epub 2014 Mar 5 [PubMed PMID: 24595959]
Le C, Bedocs PM. Neurofibromatosis. StatPearls. 2025 Jan:(): [PubMed PMID: 29083784]
Berg KT, Harrison AR, Lee MS. Perioperative visual loss in ocular and nonocular surgery. Clinical ophthalmology (Auckland, N.Z.). 2010 Jun 24:4():531-46 [PubMed PMID: 20596508]
Wu TY, Wang YX, Li XM. Applications of dynamic visual acuity test in clinical ophthalmology. International journal of ophthalmology. 2021:14(11):1771-1778. doi: 10.18240/ijo.2021.11.18. Epub 2021 Nov 18 [PubMed PMID: 34804869]
Chen W, Tang M, Jin Y, Chen L, Lin J, Yang X. Automated ultrasonographic pupillary assessment: a new neuro-ophthalmological assessment tool. The Journal of international medical research. 2024 Dec:52(12):3000605241299927. doi: 10.1177/03000605241299927. Epub [PubMed PMID: 39633596]
Reier L, Fowler JB, Arshad M, Hadi H, Whitney E, Farmah AV, Siddiqi J. Optic Disc Edema and Elevated Intracranial Pressure (ICP): A Comprehensive Review of Papilledema. Cureus. 2022 May:14(5):e24915. doi: 10.7759/cureus.24915. Epub 2022 May 11 [PubMed PMID: 35698673]
Level 2 (mid-level) evidencePhu J, Khuu SK, Yapp M, Assaad N, Hennessy MP, Kalloniatis M. The value of visual field testing in the era of advanced imaging: clinical and psychophysical perspectives. Clinical & experimental optometry. 2017 Jul:100(4):313-332. doi: 10.1111/cxo.12551. Epub 2017 Jun 22 [PubMed PMID: 28640951]
Level 3 (low-level) evidenceTopilow NJ, Tran AQ, Koo EB, Alabiad CR. Etiologies of Proptosis: A review. Internal medicine review (Washington, D.C. : Online). 2020 Mar:6(3):. doi: 10.18103/imr.v6i3.852. Epub [PubMed PMID: 32382689]
Shah HA, Shipchandler T, Vernon D, Baumanis M, Chan D, Nunery WR, Lee HBH. Extra-ocular movement restriction and diplopia following orbital fracture repair. American journal of otolaryngology. 2018 Jan-Feb:39(1):34-36. doi: 10.1016/j.amjoto.2017.08.008. Epub 2017 Aug 25 [PubMed PMID: 28969869]
Gurnani B, Kaur K. Anti-infective therapies for Pythium insidiosum keratitis. Expert review of anti-infective therapy. 2024 Oct:22(10):805-817. doi: 10.1080/14787210.2024.2403146. Epub 2024 Sep 13 [PubMed PMID: 39268901]
Lahoti A, Singh A, Bisen YT, Bakshi AM. Cutaneous Manifestations and Neurological Diseases. Cureus. 2023 Oct:15(10):e47024. doi: 10.7759/cureus.47024. Epub 2023 Oct 14 [PubMed PMID: 37965391]
Yacoub JH, Clark JA, Paal EE, Manning MA. Approach to Cystic Lesions in the Abdomen and Pelvis, with Radiologic-Pathologic Correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 2021 Sep-Oct:41(5):1368-1386. doi: 10.1148/rg.2021200207. Epub [PubMed PMID: 34469214]
Kaur K, Muralikrishnan J, Hussaindeen JR, Deori N, Gurnani B. Impact of Covid-19 on Pediatric Ophthalmology Care: Lessons Learned. Pediatric health, medicine and therapeutics. 2023:14():309-321. doi: 10.2147/PHMT.S395349. Epub 2023 Oct 12 [PubMed PMID: 37849985]
Raharja A, Whitefield L. Clinical approach to vision loss: a review for general physicians. Clinical medicine (London, England). 2022 Mar:22(2):95-99. doi: 10.7861/clinmed.2022-0057. Epub [PubMed PMID: 35304366]
Nagesh CP, Rao R, Hiremath SB, Honavar SG. Magnetic resonance imaging of the orbit, Part 2: Characterization of orbital pathologies. Indian journal of ophthalmology. 2021 Oct:69(10):2585-2616. doi: 10.4103/ijo.IJO_904_21. Epub [PubMed PMID: 34571598]
Cellina M, Cè M, Marziali S, Irmici G, Gibelli D, Oliva G, Carrafiello G. Computed tomography in traumatic orbital emergencies: a pictorial essay-imaging findings, tips, and report flowchart. Insights into imaging. 2022 Jan 12:13(1):4. doi: 10.1186/s13244-021-01142-y. Epub 2022 Jan 12 [PubMed PMID: 35022818]
Aironi VD, Gandage SG. Pictorial essay: B-scan ultrasonography in ocular abnormalities. The Indian journal of radiology & imaging. 2009 Apr-Jun:19(2):109-15. doi: 10.4103/0971-3026.50827. Epub [PubMed PMID: 19881064]
Galetta KM, Calabresi PA, Frohman EM, Balcer LJ. Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2011 Jan:8(1):117-32. doi: 10.1007/s13311-010-0005-1. Epub [PubMed PMID: 21274691]
Papasavvas I, Tucker WR, Mantovani A, Fabozzi L, Herbort CP Jr. Choroidal vasculitis as a biomarker of inflammation of the choroid. Indocyanine Green Angiography (ICGA) spearheading for diagnosis and follow-up, an imaging tutorial. Journal of ophthalmic inflammation and infection. 2024 Dec 4:14(1):63. doi: 10.1186/s12348-024-00442-w. Epub 2024 Dec 4 [PubMed PMID: 39633039]
Harrison M. Erythrocyte sedimentation rate and C-reactive protein. Australian prescriber. 2015 Jun:38(3):93-4 [PubMed PMID: 26648629]
Hrishi AP,Sethuraman M, Cerebrospinal Fluid (CSF) Analysis and Interpretation in Neurocritical Care for Acute Neurological Conditions. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine. 2019 Jun; [PubMed PMID: 31485118]
Antônio JR, Goloni-Bertollo EM, Trídico LA. Neurofibromatosis: chronological history and current issues. Anais brasileiros de dermatologia. 2013 May-Jun:88(3):329-43. doi: 10.1590/abd1806-4841.20132125. Epub [PubMed PMID: 23793209]
Marmoy OR, Viswanathan S. Clinical electrophysiology of the optic nerve and retinal ganglion cells. Eye (London, England). 2021 Sep:35(9):2386-2405. doi: 10.1038/s41433-021-01614-x. Epub 2021 Jun 11 [PubMed PMID: 34117382]
Calcagni A, Neveu MM, Jurkute N, Robson AG. Electrodiagnostic tests of the visual pathway and applications in neuro-ophthalmology. Eye (London, England). 2024 Aug:38(12):2392-2405. doi: 10.1038/s41433-024-03154-6. Epub 2024 Jun 11 [PubMed PMID: 38862643]
Ursea R, Silverman RH. Anterior-segment imaging for assessment of glaucoma. Expert review of ophthalmology. 2010 Feb 1:5(1):59-74 [PubMed PMID: 20305726]
Levin MH, Ney JJ, Venneti S, Moster ML, Balcer LJ, Volpe NJ, Gausas RE, Liu GT, Vagefi MR, Galetta SL. Optic nerve biopsy in the management of progressive optic neuropathy. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2012 Dec:32(4):313-20. doi: 10.1097/WNO.0b013e31825be81e. Epub [PubMed PMID: 22684127]
Zeppieri M, Marsili S, Enaholo ES, Shuaibu AO, Uwagboe N, Salati C, Spadea L, Musa M. Optical Coherence Tomography (OCT): A Brief Look at the Uses and Technological Evolution of Ophthalmology. Medicina (Kaunas, Lithuania). 2023 Dec 3:59(12):. doi: 10.3390/medicina59122114. Epub 2023 Dec 3 [PubMed PMID: 38138217]
Saari M, Mustonen E, Palva A, Jokinen K, Reunanen M. Arachnoid cyst of the intraorbital portion of the optic nerve with unilateral disc oedema and transient shallowing of the anterior chamber. A case report. Acta ophthalmologica. 1977 Dec:55(6):959-64 [PubMed PMID: 579549]
Level 3 (low-level) evidenceHwang K, Kim YH, Kim JH, Lee JH, Yang HK, Hwang JM, Kim CY, Han JH. The outcomes of conservatively observed asymptomatic nonfunctioning pituitary adenomas with optic nerve compression. Journal of neurosurgery. 2021 Jun 1:134(6):1808-1815. doi: 10.3171/2020.4.JNS192778. Epub 2020 Jun 5 [PubMed PMID: 32502994]
Nash TE, Mahanty S, Garcia HH, Cysticercosis Group in Peru. Corticosteroid use in neurocysticercosis. Expert review of neurotherapeutics. 2011 Aug:11(8):1175-83. doi: 10.1586/ern.11.86. Epub [PubMed PMID: 21797658]
Yu-Wai-Man P, Griffiths PG. Surgery for traumatic optic neuropathy. The Cochrane database of systematic reviews. 2013 Jun 18:6(6):CD005024. doi: 10.1002/14651858.CD005024.pub3. Epub 2013 Jun 18 [PubMed PMID: 23780732]
Level 1 (high-level) evidenceEvans AR, Villeneuve L, Bowen I, Carter L, Chen S, Kimmell M, Gernsback J, Balsara K, Jea A, Desai VR. Ventriculoperitoneal shunt placement following endoscopic third ventriculostomy failure in the treatment of pediatric hydrocephalus. Journal of neurosurgery. Pediatrics. 2024 Aug 1:34(2):176-181. doi: 10.3171/2024.4.PEDS23572. Epub 2024 May 31 [PubMed PMID: 38820604]
van Nispen RM, Virgili G, Hoeben M, Langelaan M, Klevering J, Keunen JE, van Rens GH. Low vision rehabilitation for better quality of life in visually impaired adults. The Cochrane database of systematic reviews. 2020 Jan 27:1(1):CD006543. doi: 10.1002/14651858.CD006543.pub2. Epub 2020 Jan 27 [PubMed PMID: 31985055]
Level 1 (high-level) evidenceRamesh R, Quintana D, Osorio RC, Jimenez CJ, Aghi MK, McDermott MW, Theodosopoulos PV, Goldschmidt E. Symptomatic Progression, Recurrence, and Long-Term Follow-Up of Patients With Intracranial Epidermoid Cysts. Neurosurgery. 2024 Dec 19:():. doi: 10.1227/neu.0000000000003309. Epub 2024 Dec 19 [PubMed PMID: 39699183]
Biousse V, Danesh-Meyer HV, Saindane AM, Lamirel C, Newman NJ. Imaging of the optic nerve: technological advances and future prospects. The Lancet. Neurology. 2022 Dec:21(12):1135-1150. doi: 10.1016/S1474-4422(22)00173-9. Epub 2022 Sep 22 [PubMed PMID: 36155662]
Level 3 (low-level) evidenceBrietzke SE. Individualized clinical practice guidelines: the next step in the evidence-based health care evolution? Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2014 Mar:150(3):342-5. doi: 10.1177/0194599813517864. Epub 2014 Jan 10 [PubMed PMID: 24415491]
Level 1 (high-level) evidenceGurnani B, Kaur K. Insights into career prospects after post-graduation in ophthalmology. Indian journal of ophthalmology. 2021 Dec:69(12):3709-3718. doi: 10.4103/ijo.IJO_1597_21. Epub [PubMed PMID: 34827028]
Prasad S. Diagnostic neuroimaging in neuro-ophthalmic disorders. Continuum (Minneapolis, Minn.). 2014 Aug:20(4 Neuro-ophthalmology):1023-62. doi: 10.1212/01.CON.0000453305.65851.1c. Epub [PubMed PMID: 25099107]
Leitner I, Andrianakis A, Gellner V, Kiss P, Andrianakis D, Tomazic PV. Optic nerve injury in preoperative imaging is associated with visual improvement outcome in endoscopic optic nerve decompression. Wiener klinische Wochenschrift. 2022 Mar:134(5-6):185-194. doi: 10.1007/s00508-021-01915-x. Epub 2021 Aug 3 [PubMed PMID: 34342713]
Bansal C, Lal N, Jain RC, Srivastava AN, Fatima U. Primary hydatid cyst in the soft tissue of the face: an exceptional occurrence. Indian journal of dermatology. 2011 Nov:56(6):768-70. doi: 10.4103/0019-5154.91852. Epub [PubMed PMID: 22345794]
Tang MCY, Jaarsma-Coes MG, Ferreira TA, Zwirs-Grech Fonk L, Marinkovic M, Luyten GPM, Beenakker JM. A Comparison of 3 T and 7 T MRI for the Clinical Evaluation of Uveal Melanoma. Journal of magnetic resonance imaging : JMRI. 2022 May:55(5):1504-1515. doi: 10.1002/jmri.27939. Epub 2021 Oct 15 [PubMed PMID: 34652049]
Gurnani B, Tripathy K. Minimally Invasive Glaucoma Surgery. StatPearls. 2025 Jan:(): [PubMed PMID: 35881761]
White AC Jr, Coyle CM, Rajshekhar V, Singh G, Hauser WA, Mohanty A, Garcia HH, Nash TE. Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2018 Apr 3:66(8):e49-e75. doi: 10.1093/cid/cix1084. Epub [PubMed PMID: 29481580]
Level 1 (high-level) evidenceWall PB, Traboulsi EI. Congenital abnormalities of the optic nerve: from gene mutation to clinical expression. Current neurology and neuroscience reports. 2013 Jul:13(7):363. doi: 10.1007/s11910-013-0363-2. Epub [PubMed PMID: 23703240]
Gurnani B, Kaur K, Lalgudi VG, Kundu G, Mimouni M, Liu H, Jhanji V, Prakash G, Roy AS, Shetty R, Gurav JS. Role of artificial intelligence, machine learning and deep learning models in corneal disorders - A narrative review. Journal francais d'ophtalmologie. 2024 Sep:47(7):104242. doi: 10.1016/j.jfo.2024.104242. Epub 2024 Jul 15 [PubMed PMID: 39013268]
Level 3 (low-level) evidenceGurnani B, Kaur K. Leveraging ChatGPT for ophthalmic education: A critical appraisal. European journal of ophthalmology. 2024 Mar:34(2):323-327. doi: 10.1177/11206721231215862. Epub 2023 Nov 16 [PubMed PMID: 37974429]
Gurnani B, Kaur K, Morya AK. Adoption, implementation, definitions, and future of blockchain technology in ophthalmology. Indian journal of ophthalmology. 2023 Mar:71(3):1025-1026. doi: 10.4103/ijo.IJO_1802_22. Epub [PubMed PMID: 36872733]
Hashemian H, Peto T, Ambrósio R Jr, Lengyel I, Kafieh R, Muhammed Noori A, Khorrami-Nejad M. Application of Artificial Intelligence in Ophthalmology: An Updated Comprehensive Review. Journal of ophthalmic & vision research. 2024 Jul-Sep:19(3):354-367. doi: 10.18502/jovr.v19i3.15893. Epub 2024 Sep 16 [PubMed PMID: 39359529]
Bennett CR, Bex PJ, Bauer CM, Merabet LB. The Assessment of Visual Function and Functional Vision. Seminars in pediatric neurology. 2019 Oct:31():30-40. doi: 10.1016/j.spen.2019.05.006. Epub 2019 May 11 [PubMed PMID: 31548022]
Culver SA, Grober Y, Ornan DA, Patrie JT, Oldfield EH, Jane JA Jr, Thorner MO. A Case for Conservative Management: Characterizing the Natural History of Radiographically Diagnosed Rathke Cleft Cysts. The Journal of clinical endocrinology and metabolism. 2015 Oct:100(10):3943-8. doi: 10.1210/jc.2015-2604. Epub 2015 Aug 25 [PubMed PMID: 26305621]
Level 3 (low-level) evidenceGarcia HH. Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel? Expert review of anti-infective therapy. 2008 Jun:6(3):295-8. doi: 10.1586/14787210.6.3.295. Epub [PubMed PMID: 18588494]
Kameda-Smith MM, Fathalla Z, Ibrahim N, Astaneh B, Farrokhyar F. A systematic review of the efficacy of surgical intervention in the management of symptomatic Tarlov cysts: a meta-analysis. British journal of neurosurgery. 2024 Feb:38(1):49-60. doi: 10.1080/02688697.2021.1874294. Epub 2021 Mar 23 [PubMed PMID: 33754918]
Level 1 (high-level) evidenceAlkhaibary A, Baydhi L, Alharbi A, Alshaikh AA, Khairy S, Abbas M, Abdelkhalek Aboushady AM, Almuntashri M, Alassiri AH, Alkhani A, Alferayan AA, Aloraidi A. Endoscopic versus Open Microsurgical Excision of Colloid Cysts: A Comparative Analysis and State-of-the-Art Review of Neurosurgical Techniques. World neurosurgery. 2021 May:149():e298-e308. doi: 10.1016/j.wneu.2021.02.032. Epub 2021 Feb 16 [PubMed PMID: 33601083]
Level 2 (mid-level) evidenceTevis SE, Kennedy GD. Postoperative complications and implications on patient-centered outcomes. The Journal of surgical research. 2013 May 1:181(1):106-13. doi: 10.1016/j.jss.2013.01.032. Epub 2013 Feb 9 [PubMed PMID: 23465392]
Bérczy K, Erdei C, Rajnai H, Hriczó-Koperdák G, Fancsaly-Joób Á, Kovács N. The importance of interdisciplinary collaboration in advanced therapy of odontogenic cysts: A 31 Month follow-up case report. Heliyon. 2024 Oct 30:10(20):e37587. doi: 10.1016/j.heliyon.2024.e37587. Epub 2024 Sep 12 [PubMed PMID: 39497963]
Level 3 (low-level) evidenceVesper J, Bölke B, Wille C, Gerber PA, Matuschek C, Peiper M, Steiger HJ, Budach W, Lammering G. Current concepts in stereotactic radiosurgery - a neurosurgical and radiooncological point of view. European journal of medical research. 2009 Mar 17:14(3):93-101 [PubMed PMID: 19380278]
Margolin E, Blair K, Shemesh A. Toxic and Nutritional Optic Neuropathy. StatPearls. 2025 Jan:(): [PubMed PMID: 29763154]
Kim JY, Kim HJ, Kim CH, Lee JG, Yoon JH. Optic nerve injury secondary to endoscopic sinus surgery: an analysis of three cases. Yonsei medical journal. 2005 Apr 30:46(2):300-4 [PubMed PMID: 15861507]
Level 3 (low-level) evidenceZhao L, Xie W, Li P. Severe adverse reaction induced by albendazole and praziquantel for cystic echinococcosis. IDCases. 2023:34():e01895. doi: 10.1016/j.idcr.2023.e01895. Epub 2023 Sep 7 [PubMed PMID: 37766815]
Level 3 (low-level) evidenceCoutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Molecular and cellular endocrinology. 2011 Mar 15:335(1):2-13. doi: 10.1016/j.mce.2010.04.005. Epub 2010 Apr 14 [PubMed PMID: 20398732]
Level 3 (low-level) evidenceAtaídes FG, Silva SFBR, Baldin JJCMC. Radiation-Induced Optic Neuropathy: Literature Review. Neuro-ophthalmology (Aeolus Press). 2021:45(3):172-180. doi: 10.1080/01658107.2020.1817946. Epub 2020 Nov 4 [PubMed PMID: 34194124]
Dhole S, Mahakalkar C, Kshirsagar S, Bhargava A. Antibiotic Prophylaxis in Surgery: Current Insights and Future Directions for Surgical Site Infection Prevention. Cureus. 2023 Oct:15(10):e47858. doi: 10.7759/cureus.47858. Epub 2023 Oct 28 [PubMed PMID: 38021553]
Level 3 (low-level) evidenceMilano MT, Grimm J, Soltys SG, Yorke E, Moiseenko V, Tomé WA, Sahgal A, Xue J, Ma L, Solberg TD, Kirkpatrick JP, Constine LS, Flickinger JC, Marks LB, El Naqa I. Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways. International journal of radiation oncology, biology, physics. 2021 May 1:110(1):87-99. doi: 10.1016/j.ijrobp.2018.01.053. Epub 2018 Jan 31 [PubMed PMID: 29534899]
Kinaci A, Slot EMH, Kollen M, Germans MR, Amin-Hanjani S, Carlson AP, Majeed K, Depauw PRAM, Robe PA, Regli L, Charbel FT, van Doormaal TPC. Risk Factors and Management of Incisional Cerebrospinal Fluid Leakage After Craniotomy: A Retrospective International Multicenter Study. Neurosurgery. 2023 Jun 1:92(6):1177-1182. doi: 10.1227/neu.0000000000002345. Epub 2023 Jan 23 [PubMed PMID: 36688661]
Level 2 (mid-level) evidenceElmoghazy W, Alqahtani J, Kim SW, Sulieman I, Elaffandi A, Khalaf H. Comparative analysis of surgical management approaches for hydatid liver cysts: conventional vs. minimally invasive techniques. Langenbeck's archives of surgery. 2023 Aug 18:408(1):320. doi: 10.1007/s00423-023-03043-8. Epub 2023 Aug 18 [PubMed PMID: 37594574]
Level 2 (mid-level) evidenceMahboob M, Rout P, Leslie SW, Bokhari SRA. Autosomal Dominant Polycystic Kidney Disease. StatPearls. 2025 Jan:(): [PubMed PMID: 30422529]
Gurnani B, Kaur K. Quality of life in patients with keratoconus. Indian journal of ophthalmology. 2022 Aug:70(8):3155. doi: 10.4103/ijo.IJO_927_22. Epub [PubMed PMID: 35919000]
Level 2 (mid-level) evidencevan Meerbeeck JP, Sirimsi H. Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer. Translational lung cancer research. 2015 Aug:4(4):479-83. doi: 10.3978/j.issn.2218-6751.2015.07.06. Epub [PubMed PMID: 26380191]
Bulters DO, Shenouda E, Evans BT, Mathad N, Lang DA. Visual recovery following optic nerve decompression for chronic compressive neuropathy. Acta neurochirurgica. 2009 Apr:151(4):325-34. doi: 10.1007/s00701-009-0192-x. Epub 2009 Mar 3 [PubMed PMID: 19255716]
Level 2 (mid-level) evidenceHorn R, Hendrix JM, Kramer J. Postoperative Pain Control. StatPearls. 2025 Jan:(): [PubMed PMID: 31335018]
Hayreh SS, Podhajsky PA, Zimmerman MB. Natural history of visual outcome in central retinal vein occlusion. Ophthalmology. 2011 Jan:118(1):119-133.e1-2. doi: 10.1016/j.ophtha.2010.04.019. Epub 2010 Aug 17 [PubMed PMID: 20723991]
Level 2 (mid-level) evidenceRybacka A, Karmelita-Katulska K. The Role of Computed Tomography in Monitoring Patients with Cystic Fibrosis. Polish journal of radiology. 2016:81():141-5. doi: 10.12659/PJR.896051. Epub 2016 Apr 2 [PubMed PMID: 27103945]
Galli J, Morelli F, Rigante M, Paludetti G. Management of cerebrospinal fluid leak: the importance of multidisciplinary approach. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale. 2021 Apr:41(Suppl. 1):S18-S29. doi: 10.14639/0392-100X-suppl.1-41-2021-02. Epub [PubMed PMID: 34060517]
Rafferty MR, Held Bradford EC, Fritz S, Hutchinson KJ, Miczak K, Resnick A, Billinger SA. Health Promotion and Wellness in Neurologic Physical Therapy: Strategies to Advance Practice. Journal of neurologic physical therapy : JNPT. 2022 Apr 1:46(2):103-117. doi: 10.1097/NPT.0000000000000376. Epub [PubMed PMID: 34507339]
Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, Agoritsas T, Mistry N, Iorio A, Jack S, Sivaramalingam B, Iserman E, Mustafa RA, Jedraszewski D, Cotoi C, Haynes RB. Interventions for enhancing medication adherence. The Cochrane database of systematic reviews. 2014 Nov 20:2014(11):CD000011. doi: 10.1002/14651858.CD000011.pub4. Epub 2014 Nov 20 [PubMed PMID: 25412402]
Level 1 (high-level) evidenceKurne A, Karabudak R, Yalcin-Cakmakli G, Gursoy-Ozdemir Y, Aydin P, Ilksen-Colpak A, Lule S, Kansu T. Recurrent optic neuritis: clues from a long-term follow up study of recurrent and bilateral optic neuritis patients. Eye and brain. 2010:2():15-20 [PubMed PMID: 28539758]
Lockhart E, Hawker GA, Ivers NM, O'Brien T, Mukerji G, Pariser P, Stanaitis I, Pus L, Baker GR. Engaging primary care physicians in care coordination for patients with complex medical conditions. Canadian family physician Medecin de famille canadien. 2019 Apr:65(4):e155-e162 [PubMed PMID: 30979773]
Duilio A, Cimino F, Russo T. Oligonucleotide-directed mutagenesis: a sequence-based screening. Analytical biochemistry. 1988 Nov 1:174(2):618-22 [PubMed PMID: 3239763]
Dohlman JC, Yoon MK. Principles of Protection of the Eye and Vision in Orbital Surgery. Journal of neurological surgery. Part B, Skull base. 2020 Aug:81(4):381-384. doi: 10.1055/s-0040-1714077. Epub 2020 Aug 7 [PubMed PMID: 33072480]
Patel BC, De Jesus O, Margolin E. Optic Nerve Sheath Meningioma. StatPearls. 2025 Jan:(): [PubMed PMID: 28613618]
Cozzi R, Ambrosio MR, Attanasio R, Battista C, Bozzao A, Caputo M, Ciccarelli E, De Marinis L, De Menis E, Faustini Fustini M, Grimaldi F, Lania A, Lasio G, Logoluso F, Losa M, Maffei P, Milani D, Poggi M, Zini M, Katznelson L, Luger A, Poiana C. Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors. European journal of endocrinology. 2022 Feb 3:186(3):P1-P33. doi: 10.1530/EJE-21-0977. Epub 2022 Feb 3 [PubMed PMID: 35000899]
Radtke HB, Sebold CD, Allison C, Haidle JL, Schneider G. Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors. Journal of genetic counseling. 2007 Aug:16(4):387-407 [PubMed PMID: 17636453]
Hutchinson AK, Morse CL, Hercinovic A, Cruz OA, Sprunger DT, Repka MX, Lambert SR, Wallace DK, American Academy of Ophthalmology Preferred Practice Pattern Pediatric Ophthalmology/Strabismus Panel. Pediatric Eye Evaluations Preferred Practice Pattern. Ophthalmology. 2023 Mar:130(3):P222-P270. doi: 10.1016/j.ophtha.2022.10.030. Epub 2022 Dec 19 [PubMed PMID: 36543602]
Doneddu PE, Pensato U, Iorfida A, Alberti C, Nobile-Orazio E, Fabbri A, Voza A, Study and Research Center of the Italian Society of Emergency Medicine (SIMEU). Neuropathic Pain in the Emergency Setting: Diagnosis and Management. Journal of clinical medicine. 2023 Sep 18:12(18):. doi: 10.3390/jcm12186028. Epub 2023 Sep 18 [PubMed PMID: 37762968]
Demmin DL, Silverstein SM. Visual Impairment and Mental Health: Unmet Needs and Treatment Options. Clinical ophthalmology (Auckland, N.Z.). 2020:14():4229-4251. doi: 10.2147/OPTH.S258783. Epub 2020 Dec 3 [PubMed PMID: 33299297]
Manion GN, Stokkermans TJ. Nonorganic Vision Loss. StatPearls. 2025 Jan:(): [PubMed PMID: 38261669]
Pollack AL, Brodie SE. Diagnostic yield of the routine dilated fundus examination. Ophthalmology. 1998 Feb:105(2):382-6 [PubMed PMID: 9479303]
Özge A, Domaç FM, Tekin N, Sünbül EA, Öksüz N, Atalar AÇ, Çallı SY, Fidan YS, Evlice A, Beştepe EE, İzci F, Küsbeci ÖY, Demirel EA, Velioğlu SK, Ungan M. One Patient, Three Providers: A Multidisciplinary Approach to Managing Common Neuropsychiatric Cases. Journal of clinical medicine. 2023 Sep 4:12(17):. doi: 10.3390/jcm12175754. Epub 2023 Sep 4 [PubMed PMID: 37685821]
Level 3 (low-level) evidenceAhmad SR, Moss HE. Update on the Diagnosis and Treatment of Idiopathic Intracranial Hypertension. Seminars in neurology. 2019 Dec:39(6):682-691. doi: 10.1055/s-0039-1698744. Epub 2019 Dec 17 [PubMed PMID: 31847039]
Ryan J, Virani A, Austin JC. Ethical issues associated with genetic counseling in the context of adolescent psychiatry. Applied & translational genomics. 2015 Jun 1:5():23-9. doi: 10.1016/j.atg.2015.06.001. Epub 2015 Jun 27 [PubMed PMID: 26937355]
Raabe A, Fischer U, Rothwell PM, Luengo-Fernandez R, Bervini D, Goldberg J, Trelle S, Gralla J, Beck J, Zubak I. Decision-Making for Preventive Interventions in Asymptomatic Patients. Stroke. 2024 Jul:55(7):1951-1955. doi: 10.1161/STROKEAHA.123.045106. Epub 2024 Jun 24 [PubMed PMID: 38913793]
Krist AH, Tong ST, Aycock RA, Longo DR. Engaging Patients in Decision-Making and Behavior Change to Promote Prevention. Studies in health technology and informatics. 2017:240():284-302 [PubMed PMID: 28972524]
Gala F. Magnetic resonance imaging of optic nerve. The Indian journal of radiology & imaging. 2015 Oct-Dec:25(4):421-38. doi: 10.4103/0971-3026.169462. Epub [PubMed PMID: 26752822]
Wilhelm H, Schabet M. The Diagnosis and Treatment of Optic Neuritis. Deutsches Arzteblatt international. 2015 Sep 11:112(37):616-25; quiz 626. doi: 10.3238/arztebl.2015.0616. Epub [PubMed PMID: 26396053]
Chen JJ, Kardon RH. Avoiding Clinical Misinterpretation and Artifacts of Optical Coherence Tomography Analysis of the Optic Nerve, Retinal Nerve Fiber Layer, and Ganglion Cell Layer. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2016 Dec:36(4):417-438 [PubMed PMID: 27636747]
Loebel EM, Stein LK, Fara M, Farouk S, Chadha N. Curriculum Innovations: "Eye"-ing Enhanced Educational Methods for Neurology Trainees: Pilot of an Online, Case-based Neuro-ophthalmology Interactive Workshop. Neurology. Education. 2023 Mar:2(1):e200052. doi: 10.1212/NE9.0000000000200052. Epub 2023 Mar 7 [PubMed PMID: 39411117]
Level 3 (low-level) evidenceXu TT, Kung FF, Lai KE, Ko MW, Brodsky MC, Bhatti MT, Chen JJ. Interprofessional Electronic Consultations for the Diagnosis and Management of Neuro-Ophthalmic Conditions. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2023 Mar 1:43(1):34-39. doi: 10.1097/WNO.0000000000001643. Epub 2022 Jul 8 [PubMed PMID: 36166791]
Hughes RG, O’Daniel M, Rosenstein AH. Professional Communication and Team Collaboration. Patient Safety and Quality: An Evidence-Based Handbook for Nurses. 2008 Apr:(): [PubMed PMID: 21328739]
Level 2 (mid-level) evidenceEdgman-Levitan S, Schoenbaum SC. Patient-centered care: achieving higher quality by designing care through the patient's eyes. Israel journal of health policy research. 2021 Mar 5:10(1):21. doi: 10.1186/s13584-021-00459-9. Epub 2021 Mar 5 [PubMed PMID: 33673875]
Level 2 (mid-level) evidenceFilipe HP, Silva ED, Stulting AA, Golnik KC. Continuing professional development: best practices. Middle East African journal of ophthalmology. 2014 Apr-Jun:21(2):134-41. doi: 10.4103/0974-9233.129760. Epub [PubMed PMID: 24791104]
Haddad LM, Geiger RA. Nursing Ethical Considerations. StatPearls. 2025 Jan:(): [PubMed PMID: 30252310]
Reeves S, Pelone F, Harrison R, Goldman J, Zwarenstein M. Interprofessional collaboration to improve professional practice and healthcare outcomes. The Cochrane database of systematic reviews. 2017 Jun 22:6(6):CD000072. doi: 10.1002/14651858.CD000072.pub3. Epub 2017 Jun 22 [PubMed PMID: 28639262]
Level 1 (high-level) evidence